# Chapter 59: Illness Anxiety Disorder

## The Biological and Neurological Basis of Illness Anxiety Disorder

## Introduction

Illness Anxiety Disorder (IAD) represents a significant clinical entity characterized by a persistent and excessive preoccupation with having or acquiring a serious, undiagnosed medical illness (Unknown, 2017). Formerly conceptualized as hypochondriasis, the revision in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) shifted the focus from the pejorative historical term to the core psychopathology of anxiety (Unknown, 2017; Razzak et al., 2022). This disorder is defined not by the presence of prominent physical symptoms, but by the distressing and impairing anxiety that surrounds the *possibility* of illness; if somatic symptoms are present, they are typically mild and often represent misinterpretations of normal bodily sensations, such as digestive functions or sweating (Kancherla et al., 2022; Unknown, 2017). This persistent fear continues despite normal physical examinations and negative laboratory results, leading to a chronic and often debilitating course (Kancherla et al., 2022; Unknown, 2017).

From a biological and neurological perspective, IAD can be understood as a disorder of perception, interpretation, and regulation, situated at the complex interface of mind and body (Bransfield & Friedman, 2019; Sayar, 2002). The physical symptoms that patients report are not feigned (as in malingering or factitious disorder) but are experienced as real, though their origin may lie in psychological distress rather than demonstrable tissue pathology (Egan & Kenny, 2011; Lipowski, 1987). The tendency to experience and communicate psychological distress in the form of somatic symptoms, a process known as somatization, is a ubiquitous phenomenon in medical care settings and a core feature related to IAD (Lipowski, 1986; Sayar, 2002). Patients with IAD amplify normal bodily sensations, focusing on and worrying about these perceptions in a cycle of escalating anxiety (Barsky, 1979; Pennebaker, 1994). This process is often exacerbated by psychosocial stressors, personality traits, and a tendency to interpret ambiguous information negatively (Barsky, 1979; Pennebaker, 1994).

While specific neurobiological research on IAD is less developed compared to other anxiety and mood disorders, a growing understanding suggests it shares foundational mechanisms with conditions such as Generalized Anxiety Disorder (GAD), Obsessive-Compulsive Disorder (OCD), and Major Depressive Disorder (MDD), with which it is frequently comorbid (Kancherla et al., 2022; Higueras et al., 2021; Meeke, 2011). These shared features point toward dysregulation in neural circuits responsible for threat appraisal, interoception (the sensing of internal bodily states), emotional regulation, and cognitive control (Emmett et al., 2019; Spence, 2006). The disorder is not merely a psychological overreaction but likely reflects an underlying psychobiological dysfunction (Müller, 2020), where the brain's processing of both internal sensory data and external health-related information is fundamentally altered. This chapter will synthesize the current understanding of the biological and neurological underpinnings of IAD, drawing upon research from related psychiatric and psychosomatic conditions to construct a comprehensive biopsychosocial model of this distressing and often misunderstood disorder (Krahn & Jowsey‐Gregoire, 2006).

## Neurobiological Systems

The neurobiological architecture of Illness Anxiety Disorder, while not fully elucidated through disorder-specific studies, can be inferred from our understanding of related conditions characterized by anxiety, obsessive worry, and somatic preoccupation. The pathophysiology likely involves a complex interplay of neurotransmitter systems, stress-response pathways, and specific neural circuits that govern threat perception, interoception, and cognitive control (Emmett et al., 2019; Kapfhammer, 2011).

**Neurotransmitter Systems and Neuropharmacology**

Dysregulation in key neurotransmitter systems is a central hypothesis in the etiology of anxiety and mood disorders, which are highly comorbid with IAD (Kancherla et al., 2022; Wittchen & Hoyer, 2001). The serotonergic system, in particular, is strongly implicated. Serotonin plays a crucial role in modulating mood, anxiety, and obsessive thoughts (Dreyer-Oren et al., 2018). The demonstrated efficacy of Selective Serotonin Reuptake Inhibitors (SSRIs) such as fluoxetine in treating hypochondriasis and health anxiety provides clinical evidence for the involvement of this system (Shikatani et al., 2015; Higueras et al., 2021). SSRIs are believed to correct a dysregulation of neurotransmission, acting as catalysts to restore balance in brain circuits implicated in anxiety and depressive symptoms (Barkin et al., 2000; Kennedy, 2008). The fact that higher doses of SSRIs, similar to those used for OCD, are sometimes necessary suggests that IAD may share neurobiological features with the obsessive-compulsive spectrum, involving significant serotonergic dysfunction (Hollander & Aronowitz, 1999; Merlo & Storch, 2006).

The dopaminergic system, integral to motivation, pleasure, and reward, may also be involved, particularly in the context of anhedonia and motivational deficits seen in comorbid depression (Kennedy, 2008; Dreyer-Oren et al., 2018). Furthermore, dopamine pathways are implicated in psychosis, and in severe forms of IAD where beliefs about illness reach delusional intensity (a specifier in DSM-5), dysregulation of dopaminergic activity in mesolimbic areas could be a contributing factor (Nasrallah, 2009; Fuchs, 1992). Antipsychotic medications, which primarily act on dopamine D2 receptors, have been used in cases of delusional infestation and other somatic delusional disorders, suggesting a role for dopamine in the formation and maintenance of fixed, false health beliefs (Lepping et al., 2015; Ajiboye & Yusuf, 2013).

The norepinephrine system is central to the body's "fight-or-flight" response and is implicated in the hyperarousal and autonomic symptoms common in anxiety states (Anisman & Merali, 1999; Emmett et al., 2019). In IAD, a state of hypervigilance toward bodily sensations may be driven by heightened noradrenergic tone, leading to an amplification of normal physiological signals like palpitations or sweating, which are then misinterpreted as signs of catastrophic illness (Marks & Lader, 1973; Meeke, 2011). The locus coeruleus, the brain's principal site for norepinephrine synthesis, is under regulatory control of higher cortical and limbic structures, linking cognitive appraisals of threat to physiological arousal (Emmett et al., 2019).

Finally, the GABAergic system, the primary inhibitory system in the central nervous system, is a key target for anxiolytic medications like benzodiazepines (Saeed & Bruce, 1998). A deficit in GABAergic inhibition could lead to unchecked neuronal firing in anxiety-related circuits, such as the amygdala, contributing to a state of persistent worry and tension (Emmett et al., 2019). While benzodiazepines can offer short-term relief from acute anxiety, their long-term use is discouraged due to risks of dependence and potential for worsening some symptoms (Kelly, 2012; Wacker, 1997). The complex interaction between these neurotransmitter systems—serotonin, dopamine, norepinephrine, and GABA—likely underlies the multifaceted clinical presentation of IAD, encompassing anxiety, obsessive worry, somatic hypervigilance, and, in some cases, delusional conviction (Dreyer-Oren et al., 2018; Goodwin, 2006).

**Stress Response Systems: The HPA Axis and Autonomic Nervous System**

Chronic psychological stress is a well-established risk factor for both the onset and perpetuation of a wide range of physical and mental disorders, including anxiety and depression (Pervanidou & Chrousos, 2018; House, 1987; Schneiderman et al., 2004). The physiological response to stress is mediated by two primary systems: the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system (SNS) (Anisman & Merali, 1999; Pervanidou & Chrousos, 2018). In IAD, the constant worry about health can be conceptualized as a chronic psychological stressor that maintains a state of heightened biological alert (Sikter, 2022).

The HPA axis orchestrates the release of cortisol, a glucocorticoid that modulates metabolism, immune function, and brain activity (Hellhammer & Wade, 1993). In response to perceived threats, corticotropin-releasing factor (CRF) is released from the hypothalamus, which stimulates the pituitary to release adrenocorticotropic hormone (ACTH), in turn triggering cortisol release from the adrenal glands (Emmett et al., 2019). Prolonged activation of this axis, as might be seen in chronic anxiety, can lead to dysregulation, including altered cortisol rhythms and impaired feedback inhibition (Pervanidou & Chrousos, 2018). This HPA axis dysfunction is a common finding in major depression and some anxiety disorders and is associated with a range of somatic and cognitive symptoms, including fatigue, sleep disturbances, and memory problems—symptoms that can be misinterpreted by an individual with IAD as evidence of physical disease (Dreyer-Oren et al., 2018; Hellhammer & Wade, 1993). Furthermore, chronic HPA activation and elevated cortisol can contribute to systemic inflammation and immune dysregulation, which may generate further ambiguous physical sensations that fuel the cycle of health anxiety (Wolkowitz, 2018; Bersani et al., 2019).

The autonomic nervous system (ANS) controls involuntary bodily functions, with the sympathetic branch mediating arousal and the parasympathetic branch promoting rest and recovery (Guzé, 1952). The somatic symptoms of anxiety—palpitations, sweating, trembling, shortness of breath—are direct manifestations of sympathetic activation (Marks & Lader, 1973; Palmer, 1950). In IAD, individuals exhibit a heightened sensitivity to these normal physiological fluctuations (Barsky, 1979). This may reflect a lower threshold for sympathetic activation, a deficit in parasympathetic counter-regulation, or both (Emmett et al., 2019). Reduced heart rate variability, an indicator of diminished parasympathetic tone, is a common finding in anxiety and depressive disorders and is linked to poorer health outcomes, a fact that could paradoxically reinforce the health-related fears of a patient with IAD (Kapfhammer, 2011; Giannoglou & Koskinas, 2014). This chronic state of autonomic hyperarousal not only generates the very symptoms that are misinterpreted but also contributes to a state of physical and mental exhaustion, a common complaint among those with chronic anxiety (Kapfhammer, 2006; Munir & Takov, 2021). The interplay between the HPA axis and the ANS creates a powerful feedback loop where psychological worry triggers a physiological stress response, which in turn produces somatic sensations that validate and intensify the initial health fears (Schneiderman et al., 2004).

## Genetic and Molecular Basis

The development of Illness Anxiety Disorder, like most psychiatric conditions, is understood to arise from a complex interplay of genetic predispositions and environmental factors (Ninan, 2001; Scheid & Wright, 2017). While specific genes for IAD have not been identified within the available literature, a substantial body of evidence points to a heritable component for anxiety disorders, mood disorders, and related personality traits, all of which demonstrate high rates of comorbidity with IAD (Kancherla et al., 2022; Ninan, 2001; Tariot, 1998).

**Heritability and Family Studies**

Family studies consistently demonstrate that anxiety and mood disorders aggregate within families (Ninan, 2001; Cadoret & Winokur, 1972). For instance, first-degree relatives of individuals with major depression or bipolar disorder have an elevated risk of developing these conditions themselves (Winokur & Pitts, 1965; Cadoret, 1976). Similarly, anxiety disorders show familial aggregation (Ninan, 2001). Given that IAD frequently co-occurs with GAD, panic disorder, OCD, and MDD, it is highly probable that it shares a common genetic diathesis with these conditions (Pollack, 2001; Kancherla et al., 2022; Dünner, 2001). This shared vulnerability may manifest as a general predisposition to negative affectivity or neuroticism, a personality trait with a strong genetic basis that is a robust predictor for a wide range of psychiatric disorders, including IAD (Hybels et al., 2006; Clarizio, 1989).

Twin studies, which compare concordance rates in monozygotic (identical) and dizygotic (fraternal) twins, have provided strong evidence for the heritability of conditions like schizophrenia and bipolar disorder (Räsänen et al., 1999; Cadoret & Winokur, 1972). For anxiety disorders, genetic factors are estimated to account for a significant portion of the variance in susceptibility (Ninan, 2001). It is plausible that the core features of IAD—health-related anxiety and somatic preoccupation—are heritable traits. For example, the tendency to amplify bodily sensations and interpret them negatively may be influenced by genetic factors that shape interoceptive sensitivity and cognitive processing styles (Pennebaker, 1994; Barsky, 1979).

Furthermore, a family history of significant medical illness can act as both a genetic and environmental risk factor (Noyes, 2014). Genetically, a true family history of a specific disease (e.g., heart disease, cancer) may increase an individual's objective risk, providing a kernel of truth around which excessive anxiety can crystallize (Goodwin, 2006). Environmentally, growing up in a household where illness is a prominent theme can shape an individual's beliefs and attitudes toward health, leading to heightened vigilance and catastrophic interpretations of symptoms (Reinares et al., 2019; Spijker, 2001). This suggests a gene-environment interaction, where a genetic predisposition for anxiety is activated or amplified by an environment focused on illness.

**Candidate Genes and Molecular Mechanisms**

While the provided literature does not contain specific genome-wide association studies (GWAS) for IAD, research into related disorders offers clues to potential molecular pathways. Genes involved in the regulation of the serotonin system are prime candidates, given the efficacy of SSRIs (Shikatani et al., 2015; Higueras et al., 2021). Polymorphisms in the serotonin transporter gene (SLC6A4), for example, have been extensively studied in relation to anxiety and depression, with some variants associated with increased stress sensitivity and vulnerability to mood disorders (Juruena, 2012). Similarly, genes coding for serotonin receptors (e.g., 5-HT2A) and enzymes involved in serotonin synthesis or degradation (e.g., TPH, MAO-A) are also plausible candidates (Dreyer-Oren et al., 2018).

Genes related to the HPA axis and the stress response are also of significant interest. Variations in genes for corticotropin-releasing hormone (CRH), its receptors, and the glucocorticoid receptor (NR3C1) could influence an individual's physiological reactivity to stress, potentially predisposing them to the chronic state of hyperarousal seen in IAD (Pervanidou & Chrousos, 2018; Hellhammer & Wade, 1993).

Emerging fields such as epigenetics offer a compelling mechanism for how environmental factors, particularly early life stress, translate into lasting biological vulnerability (Wolkowitz, 2018; Pervanidou & Chrousos, 2018). Traumatic or stressful early life experiences can lead to epigenetic modifications, such as DNA methylation, which alter the expression of genes involved in the stress response without changing the DNA sequence itself (Bouras & Lazaratou, 2012). Such changes, particularly in the glucocorticoid receptor gene, can lead to a lifelong sensitization of the HPA axis, resulting in an exaggerated response to stressors in adulthood (Pervanidou & Chrousos, 2018). This mechanism could explain how childhood adversity, a known risk factor for a range of psychiatric disorders, contributes to the development of IAD in genetically vulnerable individuals (Arnow, 2004; van der Kolk, 1998).

Finally, molecular processes related to inflammation and immune function are increasingly implicated in mental health (Wolkowitz, 2018; Trill, 2012). Chronic stress and depression are associated with elevated levels of pro-inflammatory cytokines (e.g., IL-1, IL-6, TNF-alpha), which can induce "sickness behaviors" such as fatigue, malaise, and pain—symptoms that form the basis of misinterpretation in IAD (Trill, 2012; Ferguson & Cassaday, 2001). Genetic variations that lead to a pro-inflammatory phenotype could therefore represent another layer of biological vulnerability, creating a somatic substrate that is readily amplified by psychological factors (Bersani et al., 2019).

## Brain Structure and Function

The core psychopathology of Illness Anxiety Disorder—a preoccupation with illness based on the misinterpretation of bodily symptoms (LATHAM, 2006)—points toward dysfunction in specific brain networks responsible for interoception, threat assessment, and cognitive control. Although neuroimaging studies specifically targeting IAD are sparse in the provided literature, findings from research on related conditions such as medically unexplained symptoms (MUS), conversion disorder, and other anxiety disorders provide a strong foundation for a neuroanatomical model of the disorder (Spence, 2006).

**Neuroimaging Findings: Structural and Functional**

Functional neuroimaging has been instrumental in elucidating the neural correlates of unexplained physical symptoms, revealing patterns of brain activity that differ between patients and healthy controls (Spence, 2006). A key framework suggests that psychiatric syndromes impacting bodily awareness signal dysfunction within brain systems that represent the body and its performance (Spence, 2006). For IAD, this involves a disturbance in the processing of interoceptive signals—the perception of the body's internal state.

The insular cortex, a brain region critical for interoceptive awareness, is a primary candidate for dysfunction in IAD. The insula integrates sensory information from the body with emotional and cognitive processes, creating a subjective awareness of our internal state (Nasrallah, 2014). Hyperactivity or altered connectivity of the insula could lead to an intensified perception of normal bodily sensations, making benign physiological events feel more salient and alarming (Nasrallah, 2014; Chen et al., 2012). This heightened visceral sensitivity provides a constant stream of "data" that is then catastrophically misinterpreted by other brain regions (Barsky, 1979).

The amygdala, a central hub in the brain's fear and threat detection circuitry, is robustly implicated in all anxiety disorders (Emmett et al., 2019; Wetherell et al., 2007). In IAD, the amygdala may be hyper-responsive not only to external health-related cues (e.g., a news report about a disease) but also to the ambiguous internal signals relayed from the insula (Emmett et al., 2019). This would trigger a fear response, complete with autonomic arousal, to sensations that would otherwise be filtered out as non-threatening (Mineka et al., 1991). This amygdala hyperactivity might explain the persistent state of "apprehensive expectation" that characterizes IAD (Szkodny et al., 2014).

Crucially, the regulation of this threat response is managed by the prefrontal cortex (PFC), particularly the medial PFC and orbitofrontal cortex (OFC) (Nasrallah, 2014). The PFC exerts top-down inhibitory control over the amygdala, allowing for the contextual appraisal of threats and the suppression of fear responses when they are unwarranted (Emmett et al., 2019). A core hypothesis in anxiety disorders is that this top-down control is deficient (Dreyer-Oren et al., 2018). In IAD, hypoactivity in the PFC could result in a failure to reappraise catastrophic thoughts about health and an inability to inhibit the fear response triggered by the amygdala (Meeke, 2011). This aligns with the clinical observation that patients find it difficult to control their worry, even when they recognize it might be excessive (Munir & Takov, 2021; Unknown, 2017). Structural MRI studies in related disorders have found reduced gray matter volume in prefrontal regions, suggesting a potential structural basis for this functional deficit (Nasrallah, 2014).

The anterior cingulate cortex (ACC) is another key region, involved in error detection, conflict monitoring, and the emotional experience of pain (Derbyshire & Bremner, 2009). The ACC may play a role in IAD by biasing attention toward bodily sensations and flagging them as "problematic," thereby amplifying their perceived significance (Derbyshire & Bremner, 2009). Altered activity in the ACC is a common finding in depression and anxiety, and could contribute to the persistent distress and rumination about health that defines IAD (Dreyer-Oren et al., 2018; Nasrallah, 2014).

Finally, the basal ganglia, particularly the caudate nuclei, have been implicated in syndromes involving repetitive thoughts and behaviors, such as OCD (Spence, 2006). Research on body dysmorphic disorder (BDD), another disorder involving preoccupation and repetitive behaviors, suggests dysfunction in fronto-striatal circuits (Phillips, 2014). Given the obsessive nature of health worries and the compulsive checking behaviors (e.g., self-examination, seeking reassurance, internet searching) seen in IAD, it is plausible that similar fronto-striatal circuit dysregulation is involved (Kancherla et al., 2022; Hollander & Aronowitz, 1999). Spence (2006) notes that the caudate nuclei are implicated in a variety of syndromes, including somatization, suggesting a role for these structures in the processing of and response to bodily symptoms.

In summary, the neuroimaging literature, primarily from related disorders, points to a model of IAD characterized by a dysfunctional neural circuit. This circuit involves: 1) a hyperactive insula, leading to heightened interoceptive awareness; 2) a hyper-reactive amygdala, which interprets these sensations as threatening; 3) a hypoactive PFC, which fails to regulate the ensuing fear and worry; and 4) a dysregulated ACC and fronto-striatal system, which contribute to attentional bias, rumination, and compulsive checking behaviors (Spence, 2006; Nasrallah, 2014; Emmett et al., 2019).

## Developmental Neurobiology

Illness Anxiety Disorder, like many psychiatric conditions, is best understood through a developmental lens, recognizing that its origins often lie in early life and its expression evolves across the lifespan (Clarizio, 1989; Scheid & Wright, 2017). The interplay between innate temperament, early life experiences, and critical developmental periods shapes the neurobiological vulnerability that ultimately manifests as the disorder (Pervanidou & Chrousos, 2018).

**Early Onset and Critical Periods**

Anxiety disorders frequently have their onset in childhood or adolescence (Kessler & Wang, 2008; Bagnell, 2011). Social anxiety disorder, for example, typically begins by the teenage years and follows a chronic course (Schneier et al., 2014; Lépine & Pélissolo, 2000). While specific onset data for IAD is limited in the provided sources, its conceptualization as a chronic condition rooted in anxiety suggests a similar early trajectory (Unknown, 2017). Early life, from infancy through adolescence, represents a critical period for the development of neural circuits that regulate emotion and stress (Pervanidou & Chrousos, 2018; Singh, 2015).

Temperamental traits observable in infancy, such as behavioral inhibition—a tendency to be shy, anxious, and avoidant in new situations—are known risk factors for the later development of anxiety disorders (Bagnell, 2011). This innate predisposition may reflect an underlying neurobiological hyper-reactivity in threat-processing circuits, such as the amygdala (Emmett et al., 2019). A child with this temperament may be more prone to developing fears, including those related to bodily harm and illness (Wissow, 2021).

Early childhood is also when foundational beliefs about the world, the self, and the body are formed (Reinares et al., 2019). Experiences with illness, either personal or within the family, can have a profound impact during this period (Carey, 1969). A serious childhood illness or frequent medical procedures can sensitize a child to bodily sensations and medical environments, creating a learned association between physical symptoms and fear (Perrin et al., 2012; Wissow, 2021). Similarly, observing a parent with a chronic illness or high health anxiety can lead to modeling of illness behavior and catastrophic interpretations of symptoms (Reinares et al., 2019; Spijker, 2001). This learning process can shape neural pathways, reinforcing a pattern of hypervigilance and anxious responding to health-related stimuli (van der Kolk, 1998).

Adolescence represents another critical period, marked by significant hormonal changes, brain maturation (particularly in the prefrontal cortex), and increasing social and academic pressures (Gutton, 1980; Sharma et al., 2014). The onset of many psychiatric disorders, including depression and psychosis, peaks during this time (McGorry & Yung, 2020; Remschmidt & Theisen, 2012). The developing adolescent brain, with its still-maturing capacity for top-down cognitive control from the PFC, may be particularly vulnerable to the development of uncontrollable worry, a core feature of both GAD and IAD (Imran et al., 2017; Catheline, 2005). The emergence of abstract thought can also enable more complex and future-oriented worries about potential diseases (Catheline, 2005).

**The Role of Early Life Stress and Trauma**

Exposure to early life stress, including childhood abuse, neglect, or significant family dysfunction, is a powerful, non-specific risk factor for a vast range of adult psychiatric and physical health problems (Arnow, 2004; van der Kolk, 1998; Copeland‐Linder et al., 2017). The biological mechanisms for this link are increasingly understood to involve the "programming" of the stress response systems (Pervanidou & Chrousos, 2018). Chronic or severe stress during development can lead to lasting changes in the HPA axis and autonomic nervous system, creating a state of heightened stress reactivity that persists into adulthood (Hellhammer & Wade, 1993; Meyer & Hamel, 2014).

From a neurobiological standpoint, early trauma can alter the development of key brain regions, including the hippocampus, amygdala, and prefrontal cortex (Hoon, 2012; Pervanidou & Chrousos, 2018). These structural and functional changes can lead to impairments in memory, emotional regulation, and executive function, which are core deficits across many psychiatric disorders (Bouras & Lazaratou, 2012). For an individual who develops IAD, this neurobiological vulnerability might manifest as an inability to regulate fear related to health, a tendency to be trapped in intrusive memories of past illnesses (personal or familial), and a cognitive bias toward interpreting ambiguous bodily sensations as threatening (Kapfhammer, 2018; van der Kolk, 1998). The experience of the body as a source of pain or threat, rather than safety, can become a deeply ingrained schema, providing fertile ground for the development of illness anxiety (Pennebaker, 1994; Sayar, 2002). Therefore, the developmental trajectory of IAD is likely one where a constitutional vulnerability, perhaps expressed as an anxious temperament, interacts with adverse early life experiences—be it direct medical trauma, observation of illness, or broader psychosocial stress—to shape a neurobiology primed for the misinterpretation of bodily signals and chronic health-related worry (Perrin et al., 2012; Arnow, 2004).

## Treatment Mechanisms

The management of Illness Anxiety Disorder involves interventions that target the underlying biological and psychological drivers of the condition. While direct evidence from the provided sources is specific to a few modalities, the principles can be extrapolated from treatments for related anxiety, obsessive-compulsive, and depressive disorders. The primary evidence-based approaches are pharmacotherapy, particularly with SSRIs, and psychotherapy, most notably Cognitive Behavioral Therapy (CBT) (Shikatani et al., 2015; Higueras et al., 2021). These treatments are believed to work by modulating dysfunctional neural circuits and promoting neuroplasticity.

**Neuroplasticity and Pharmacotherapy**

Pharmacological treatment for IAD, as with comorbid anxiety and depression, often involves SSRIs (Shikatani et al., 2015; Higueras et al., 2021). The neurobiological mechanism of SSRIs is the blockade of the serotonin transporter, which increases the synaptic availability of serotonin (Kennedy, 2008). This is thought to correct a hypothesized dysregulation in the serotonergic system, which is crucial for mood and anxiety regulation (Dreyer-Oren et al., 2018; Barkin et al., 2000).

The therapeutic effects of SSRIs are not immediate, typically taking several weeks to manifest, suggesting that their benefit extends beyond simple neurotransmitter level correction (Mandos et al., 2009). This delay is thought to reflect downstream effects on neuroplasticity—the brain's ability to reorganize its structure, function, and connections in response to experience (Wolkowitz, 2018). Chronic SSRI administration may promote neurogenesis (the birth of new neurons), particularly in the hippocampus, a region implicated in both depression and anxiety and vulnerable to the effects of chronic stress (Dreyer-Oren et al., 2018; Meyer & Hamel, 2014). By enhancing neuroplasticity, SSRIs may help to remodel the dysfunctional circuits underlying IAD. Specifically, they may dampen the hyper-reactivity of the amygdala to perceived health threats and strengthen top-down regulatory control from the prefrontal cortex (PFC), thereby reducing the intensity of fear and worry (Emmett et al., 2019; Holtzheimer & Hamani, 2014). This modulation of the amygdala-PFC circuit is a core mechanism proposed for the anxiolytic effects of antidepressants (Dreyer-Oren et al., 2018). In cases where health beliefs are delusional, atypical antipsychotics may be used, which primarily modulate dopamine pathways and can help correct the distorted thinking associated with psychosis (Lepping et al., 2015; Nasrallah, 2009).

**Cognitive Behavioral Therapy and Compensatory Mechanisms**

Cognitive Behavioral Therapy (CBT) is considered a first-line treatment for anxiety disorders, including IAD (Shikatani et al., 2015; Bothwell, 2003). CBT operates on the principle that maladaptive thoughts, feelings, and behaviors are interconnected and can be changed through targeted interventions (Warnock‐Parkes et al., 2022). From a neurobiological perspective, CBT is a form of structured learning that induces neuroplastic changes in the brain (Holtzheimer & Hamani, 2014).

The cognitive component of CBT for IAD involves identifying and restructuring catastrophic thoughts and dysfunctional beliefs about health and illness (Warnock‐Parkes et al., 2022; Meeke, 2011). For example, a patient might learn to challenge the automatic thought "This headache must be a brain tumor" and replace it with a more balanced and evidence-based alternative (Spence, 2006; Lemogne et al., 2019). This process of cognitive restructuring is believed to strengthen the function of the PFC, enhancing its ability to regulate emotional responses generated by the amygdala (Dreyer-Oren et al., 2018). By repeatedly engaging in this reappraisal process, patients can effectively "retrain" their brains to respond to ambiguous bodily sensations with less fear and catastrophization (Meeke, 2011).

The behavioral component of CBT for IAD often involves exposure and response prevention (ERP) (Shikatani et al., 2015; Higueras et al., 2021). Exposure involves gradually and systematically confronting feared bodily sensations (interoceptive exposure) or situations (e.g., reading about an illness) without engaging in safety-seeking or reassurance-seeking behaviors (response prevention) (Taylor et al., 2012). For example, a patient who fears having a heart attack might be guided to engage in light exercise to elevate their heart rate and learn that the sensation is not dangerous (Bothwell, 2003). This process works through the mechanism of habituation and extinction learning. Repeated exposure to the feared stimulus without the anticipated catastrophic outcome weakens the learned fear association in the amygdala and strengthens new, non-fearful associations mediated by the PFC (Holtzheimer & Hamani, 2014). Response prevention, such as refraining from checking one's pulse or seeking reassurance from a doctor, is critical because these behaviors prevent the brain from learning that the feared outcome does not occur, thereby maintaining the anxiety cycle (Taylor et al., 2012).

Through these combined cognitive and behavioral techniques, CBT helps patients develop compensatory mechanisms. It strengthens top-down cognitive control, recalibrates threat appraisal systems, and extinguishes maladaptive fear responses, leading to lasting changes in the neural circuits that sustain illness anxiety (Meeke, 2011; Warnock‐Parkes et al., 2022). This process of actively engaging in new ways of thinking and behaving drives neuroplasticity, creating more resilient and adaptive neural pathways for interpreting and responding to health-related information (Silverman & Deuster, 2014).

## Biological Subtypes and Heterogeneity

Illness Anxiety Disorder, like many psychiatric conditions, is not a monolithic entity but rather a heterogeneous syndrome (Yutzy, 2015; Kapfhammer, 2011). Patients present with a wide spectrum of symptom severity, comorbidity, and underlying psychological mechanisms, suggesting the existence of distinct biological subtypes (Wittchen & Hoyer, 2001). Although the provided literature does not formally define these subtypes, a dimensional and comorbidity-based approach allows for the postulation of several neurobiologically distinct profiles.

One major source of heterogeneity lies in the degree of somatic symptom presence. The DSM-5 criteria for IAD specify that somatic symptoms are absent or, if present, are only mild in intensity (Kancherla et al., 2022). This distinguishes IAD from Somatic Symptom Disorder (SSD), where one or more distressing somatic symptoms are prominent (Yutzy, 2015; Henningsen, 2018). This distinction suggests at least two potential subtypes: a "pure" cognitive-anxious subtype, primarily driven by catastrophic thoughts and worry in the absence of significant physical sensations, and a "somatosensory" subtype, where mild but persistent or noticeable bodily sensations serve as the constant trigger for health anxiety (Sayar, 2002; Righter & Sansone, 1999). The "pure" subtype might be associated with greater dysfunction in top-down cognitive control circuits involving the prefrontal cortex (PFC), consistent with models of GAD and obsessive worry (Meeke, 2011; Szkodny et al., 2014). In contrast, the "somatosensory" subtype might be characterized by heightened activity and connectivity of the insula and somatosensory cortices, leading to an amplified perception of bodily signals—a phenomenon known as somatosensory amplification (Barsky, 1979; Pennebaker, 1994). This latter group may overlap significantly with patients who have functional somatic syndromes like irritable bowel syndrome or fibromyalgia, where visceral or musculoskeletal hypersensitivity is a key feature (Derbyshire & Bremner, 2009; Häuser et al., 2012).

A second axis of heterogeneity is defined by the pattern of comorbid psychiatric disorders, which are exceedingly common in IAD (Kancherla et al., 2022; Higueras et al., 2021). An "anxious-depressive" subtype can be proposed for patients where IAD coexists with Major Depressive Disorder (MDD) or dysthymia (Pollack, 2001). In these individuals, the neurobiology may be more aligned with that of mood disorders, characterized by significant HPA axis dysregulation, inflammatory changes, and altered function in limbic and prefrontal circuits underlying mood regulation and anhedonia (Dreyer-Oren et al., 2018; Goodwin, 2006; Kapfhammer, 2006). Their health anxiety may be thematically linked to depressive cognitions of hopelessness, worthlessness, and a bleak future (Blazer & Hybels, 2005). This contrasts with a "panic-spectrum" subtype, where IAD is comorbid with panic disorder. Here, the core fear might be a catastrophic misinterpretation of acute autonomic arousal symptoms (e.g., palpitations, dizziness), with the underlying neurobiology showing greater involvement of brainstem and midbrain structures (like the periaqueductal gray) involved in acute fear responses (Wittmann, 2020; Margraf et al., 1987).

A third potential subdivision relates to the level of insight, which can range from good/fair to poor to absent/delusional (Phillips, 2014). Patients with good insight may recognize their health fears as excessive, even while struggling to control them (LATHAM, 2006). This profile suggests relatively intact prefrontal functioning but a hyperactive emotional response from the amygdala. In contrast, patients with absent insight or delusional beliefs (i.e., a conviction of illness that is unshakeable) may represent a more severe form of the disorder that borders on a psychotic process (Manschreck, 1996; Fuchs, 1992). This "delusional" subtype, classified as Delusional Disorder, Somatic Type, or IAD with absent insight, might involve more profound dysfunction in reality-testing circuits and potentially greater involvement of the dopaminergic system, similar to other delusional disorders (Ajiboye & Yusuf, 2013; Lepping et al., 2015). This distinction has significant treatment implications, as this group may be less responsive to standard psychotherapy and may require antipsychotic medication (Manschreck, 1996).

Finally, the etiology and developmental pathway may delineate subtypes. Some cases may be precipitated by a significant medical event or trauma, suggesting a pathway related to post-traumatic stress, where fear conditioning and memory consolidation circuits are prominently involved (Kancherla et al., 2022; van der Kolk, 1998). Other cases may arise more insidiously, linked to long-standing personality traits like neuroticism or a family history of anxiety, pointing to a more constitutionally and genetically determined vulnerability (Ninan, 2001; Hybels et al., 2006). These differing pathways likely correspond to distinct neurobiological signatures, highlighting the need for a personalized approach to diagnosis and treatment that considers the unique clinical and biological profile of each patient (Scheid & Wright, 2017).

## Future Directions

The biological and neurological understanding of Illness Anxiety Disorder is still in its nascent stages, with much of the current knowledge extrapolated from related psychiatric conditions. The available literature, while extensive in its coverage of anxiety, depression, and somatic symptoms, highlights significant gaps that represent critical avenues for future research. A primary goal for the field must be to move beyond analogy and establish a disorder-specific neurobiological model for IAD.

First, dedicated neuroimaging studies of IAD are urgently needed. While the implication of the insula, amygdala, prefrontal cortex, and anterior cingulate cortex is a robust hypothesis based on research into anxiety and interoception (Spence, 2006; Nasrallah, 2014), studies that directly compare well-characterized IAD patients with healthy controls and other clinical groups (e.g., GAD, SSD, OCD) are essential. Functional MRI (fMRI) studies could use tasks that probe interoceptive accuracy, the interpretation of ambiguous health information, or the regulation of anxiety in response to symptom-related cues. Such research could clarify whether IAD is characterized by a primary deficit in sensory processing (e.g., insula hyperactivity), emotional appraisal (e.g., amygdala hyper-reactivity), cognitive control (e.g., PFC hypoactivity), or a combination thereof (Dreyer-Oren et al., 2018). Resting-state functional connectivity analyses could also map the intrinsic network organization that predisposes individuals to health anxiety, potentially revealing unique patterns of connectivity within and between the salience, default mode, and executive control networks.

Second, the genetic and molecular basis of IAD remains largely unexplored. Future research should include genome-wide association studies (GWAS) to identify specific genetic variants that confer risk for IAD (Stringer et al., 2015). Given the high comorbidity, it will be crucial to determine whether these genetic markers are specific to IAD or are part of a broader genetic liability for anxiety and depressive disorders (Ninan, 2001). Epigenetic studies, investigating how environmental factors like early life stress or medical trauma alter gene expression (e.g., DNA methylation of stress-related genes like NR3C1), could provide a powerful link between lived experience and biological vulnerability (Pervanidou & Chrousos, 2018; Wolkowitz, 2018). This line of inquiry could help explain why only some individuals who experience a medical scare or grow up in an illness-focused environment go on to develop the disorder (Arnow, 2004).

Third, the role of the immune and endocrine systems warrants deeper investigation. The "sickness behavior" model, driven by pro-inflammatory cytokines, provides a compelling link between physiological states and the subjective experience of being ill (Ferguson & Cassaday, 2001; Trill, 2012). Research is needed to explore whether individuals with IAD have a baseline pro-inflammatory state, or an exaggerated inflammatory response to psychological stress, which could generate the mild somatic sensations that fuel their health worries. Similarly, more detailed characterization of HPA axis function in IAD, using dynamic testing like the dexamethasone-CRH test, could clarify its role beyond what is known from general depression and anxiety research (Hellhammer & Wade, 1993; Steinberg, 1981).

Fourth, a better understanding of the biological mechanisms of treatment is necessary. While we know SSRIs and CBT are effective, the precise neural changes they induce in IAD patients are unknown (Shikatani et al., 2015). Longitudinal neuroimaging studies that assess brain structure and function before and after treatment could identify the neural circuits that are modified by successful intervention. This could lead to the development of biomarkers to predict treatment response and help tailor therapies to individual patients. For example, one might find that patients with primary PFC dysfunction respond better to cognitive therapy, while those with primary amygdala-insula hyperactivity benefit more from SSRIs or exposure-based techniques (Meeke, 2011).

Finally, future research must embrace the heterogeneity of the disorder. Studies should aim to identify and validate distinct neurobiological subtypes of IAD, as discussed previously. Comparing the neural profiles of patients with and without significant somatic symptoms, with delusional versus non-delusional beliefs, or with different patterns of psychiatric comorbidity will be crucial for refining diagnostic categories and developing more targeted and effective treatments (Yutzy, 2015; Kapfhammer, 2011). This research will not only advance our understanding of IAD but will also contribute to the broader field of psychosomatic medicine by illuminating the complex and bidirectional relationship between the brain, the body, and the subjective experience of illness (Dragoș & Tănăsescu, 2009).

## Conclusion

Illness Anxiety Disorder, characterized by the debilitating fear of having a serious disease, represents a profound disruption at the intersection of psychology and biology. While its classification has evolved from the historical concept of hypochondriasis to a specific anxiety-related diagnosis, the underlying neurobiological mechanisms are only beginning to be understood (Unknown, 2017; Yutzy, 2015). This chapter has synthesized evidence from a broad but constrained body of literature to construct a preliminary biopsychosocial model of IAD, acknowledging that much of the specific neural and molecular data must be inferred from related conditions.

The emerging picture suggests that IAD is not a mere psychological overreaction but a disorder rooted in the dysregulation of fundamental brain systems. Neurobiologically, it appears to involve a dysfunctional circuit comprising brain regions responsible for sensing the body's internal state (the insula), appraising threat (the amygdala), and exerting cognitive control over worry and fear (the prefrontal cortex) (Spence, 2006; Emmett et al., 2019). Individuals with IAD may experience an amplified awareness of normal bodily sensations, a hyper-reactive threat response to this interoceptive information, and a diminished capacity for top-down regulation of the resulting anxiety. This core dysfunction is likely sustained by alterations in key neurotransmitter systems, including serotonin, norepinephrine, and GABA, and is exacerbated by chronic activation of the body's stress response systems, namely the HPA axis and the autonomic nervous system (Dreyer-Oren et al., 2018; Pervanidou & Chrousos, 2018).

The vulnerability to developing this neurobiological profile is shaped by a confluence of factors. A genetic predisposition, likely shared with other anxiety and mood disorders, sets the stage (Ninan, 2001). This innate vulnerability is then molded by developmental experiences, where early life stress, medical trauma, or exposure to illness can program the stress and threat-detection systems for a lifetime of hyper-reactivity (van der Kolk, 1998; Arnow, 2004). The heterogeneity of the disorder reflects the varied contributions of these factors, resulting in different clinical presentations, from a purely cognitive preoccupation to a more somatosensory-driven anxiety, and from well-retained insight to delusional conviction (Yutzy, 2015; Manschreck, 1996).

This biological framework provides a clear rationale for the efficacy of current evidence-based treatments. Pharmacotherapies like SSRIs likely work by modulating the serotonergic pathways within these dysfunctional circuits, while psychotherapies such as CBT drive neuroplasticity by helping patients restructure catastrophic thoughts and extinguish conditioned fear responses through exposure (Shikatani et al., 2015; Holtzheimer & Hamani, 2014). Ultimately, understanding IAD as a brain-based disorder helps to destigmatize the condition, moving it away from pejorative labels and toward a model of genuine, treatable suffering (Bransfield & Friedman, 2019). While much research is still needed to delineate the specific biological signatures of IAD, the current evidence provides a solid foundation for a comprehensive, integrated approach to care that respects the reality of the patient's distress while targeting the underlying neurobiological mechanisms that perpetuate it.

## References

1. Adler, G. (2006). Diagnostik der Demenz. Notfall & Hausarztmedizin (Notfallmedizin). https://doi.org/10.1055/s-2006-959110
2. Aghababaeian, H., & Ahvazi, L. A. (2018). Isn’t it Time to Use Opioid Drugs in Emergency Medical Services?. DOAJ (DOAJ: Directory of Open Access Journals).
3. Ajiboye, P., & Yusuf, A. D. (2013). Scientific Letter: Monosymptomatic Hypochondriacal Psychosis (somatic delusional disorder): A report of two cases. African Journal of Psychiatry. https://doi.org/10.4314/ajpsy.v16i2.11
4. Alanbagi, A. A., & Al-Zamily, R. H. (2019). The depression among cancer patients during chemotherapy and its relation to demographic and social data. International Journal of Research in Pharmaceutical Sciences.
5. Alchieri, J. C., & Urquijo, S. (2022). Aspectos demenciais frontotemporais como desafios em processos periciais psicológicos. Revista Psicologia Jurídica Forense. https://doi.org/10.56492/issn.27647374.2022n1a1
6. Allan, C. E., Valkanova, V., & Ebmeier, K. P. (2014). Depression in older people is underdiagnosed.. PubMed.
7. Altamura, A., Cattaneo, E., Pozzoli, S., Bassetti, R., & Sacco, L. (2006). Inquadramento diagnostico e gestione farmacologica della depressione senile Assessment and pharmacological management of elderly depression.
8. Ambrosino, N., & Serradori, M. (2006). Determining the cause of dyspnoea: linguistic and biological descriptors. Chronic Respiratory Disease. https://doi.org/10.1191/1479972306cd110ra
9. Anderson, T., Heitger, M., & Macleod, A. D. (2006). Concussion and mild head injury. Practical Neurology. https://doi.org/10.1136/jnnp.2006.106583
10. Andrasik, F., Lipchik, G. L., McCrory, D. C., & Wittrock, D. A. (2005). Outcome Measurement in Behavioral Headache Research: Headache Parameters and Psychosocial Outcomes. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.2005.05094.x
11. Anisman, H., & Merali, Z. (1999). Understanding stress: characteristics and caveats.. PubMed.
12. Ariff, K. M., & Hassan, Z. A. (2006). Insomnia: Case Studies In Family Practice.. DOAJ (DOAJ: Directory of Open Access Journals).
13. Armstrong, L. E., Casa, D. J., Millard‐Stafford, M., Moran, D. S., Pyne, S. W., & Roberts, W. O. (2007). Exertional Heat Illness during Training and Competition. Medicine & Science in Sports & Exercise. https://doi.org/10.1249/mss.0b013e31802fa199
14. Arnow, B. A. (2004). Relationships between childhood maltreatment, adult health and psychiatric outcomes, and medical utilization.. PubMed.
15. Arredondo-Aldana, K., Mera-Posligua, M. J., & Alencastro, J. A. P. (2021). Trastorno Depresivo Persistente y Trastornos de Ansiedad Generalizada Proveniente de un Estrés Post Traumático Crónico: Presentación de un Caso Clínico. Revista Científica Arbitrada en Investigaciones de la Salud GESTAR. https://doi.org/10.46296/gt.v4i8edesp.0027
16. Autor, S. (2002). CÁPSULAS PARA LA VIDA.- ANSIEDAD. Gaceta UNAM (2000-2009).
17. Avari, J., Yuen, G. S., AbdelMalak, B., Mahgoub, N., Kalayam, B., & Alexopoulos, G. S. (2014). Assessment and Management of Late-Life Depression. Psychiatric Annals. https://doi.org/10.3928/00485713-20140306-04
18. Ba, V. D. K. (1998). [Psychology and psychobiology of childhood trauma].. PubMed.
19. Bagnell, A. (2011). Anxiety and Separation Disorders. Pediatrics in Review. https://doi.org/10.1542/pir.32.10.440
20. Baldwin, D. S., Ajel, K., & Garner, M. (2008). Anxiety disorders. Medicine. https://doi.org/10.1016/j.mpmed.2008.05.002
21. Balhara, Y. P. S., Mohan, I., Sagar, R., & Chawla, J. (2006). Chronic mania: An unexpectidly long episode?. Indian Journal of Medical Sciences. https://doi.org/10.4103/0019-5359.25681
22. Ballinger, C. (1976). Mental Health Aspects. Royal Society of Health Journal. https://doi.org/10.1177/146642407609600211
23. Bandelow, B., & Michaelis, S. (2015). Epidemiology of anxiety disorders in the 21st century. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2015.17.3/bbandelow
24. Baran, A. S., & Chervin, R. D. (2009). Approach to the Patient with Sleep Complaints. Seminars in Neurology. https://doi.org/10.1055/s-0029-1237116
25. Barkin, R. L., Schwer, W. A., & Barkin, S. J. (2000). Recognition and Management of Depression in Primary Care. American Journal of Therapeutics. https://doi.org/10.1097/00045391-200007030-00008
26. Barolin, G. S. (1998). Rehabilitation hospitalism. International Journal of Rehabilitation Research. https://doi.org/10.1097/00004356-199806000-00008
27. Barr, R. G. (2006). Crying Behaviour and Its Importance for Psychosocial Development in Children.
28. Barros, S. M., Araújo, D. B. D., & Carvalho, J. F. D. (2020). Suicide risk in systemic lupus erythematosus: a narrative review. Revista de Ciências Médicas e Biológicas. https://doi.org/10.9771/cmbio.v19i4.24308
29. Barsky, A. J. (1979). Patients Who Amplify Bodily Sensations. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-91-1-63
30. Barsky, A. J. (1999). Functional Somatic Syndromes. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-130-11-199906010-00016
31. Barton, S., Karner, C., Salih, F., Baldwin, D. S., & Edwards, S. J. (2014). Clinical effectiveness of interventions for treatment-resistant anxiety in older people: a systematic review. Health Technology Assessment. https://doi.org/10.3310/hta18500
32. Bass, C., & Wade, D. T. (2018). Malingering and factitious disorder. Practical Neurology. https://doi.org/10.1136/practneurol-2018-001950
33. Baum, R., & Campo, J. V. (2022). Medically Unexplained Symptoms. Pediatric Care Online. https://doi.org/10.1542/aap.ppcqr.396501
34. Beghi, E., Carpio, A., Forsgren, L., Hesdorffer, D. C., Malmgren, K., Sander, J. W., Tomson, T., & Hauser, W. A. (2009). Recommendation for a definition of acute symptomatic seizure. Epilepsia. https://doi.org/10.1111/j.1528-1167.2009.02285.x
35. Berg, J., & Grimeland, J. (2012). Obsessive-compulsive disorder in disguise—Case report. Open Journal of Psychiatry. https://doi.org/10.4236/ojpsych.2012.23026
36. Bersani, F. S., Mellon, S. H., Reus, V. I., & Wolkowitz, O. M. (2019). Accelerated aging in serious mental disorders. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0000000000000525
37. Bhat, M. (1996). Outcome of rehabilitation programme: Is there a differential response?. European Psychiatry. https://doi.org/10.1016/0924-9338(96)88851-1
38. Bhingardive, S. S., & Salve, P. (2022). Assessment of Knowledge Regarding Postpartum Psychiatric Disorders Among the Relatives of Primigravida in Selected Hospitals of the City. Acta Scientific Women s Health. https://doi.org/10.31080/aswh.2022.04.0340
39. Biggs, Q. M., Guimond, J. M., Fullerton, C. S., Ursano, R. J., Gray, C. L., Goldenberg, M., Reissman, D. B., McCarroll, J. E., Santiago, P. N., & Tyler, M. P. (2012). The Epidemiology of Acute Stress Disorder and Other Early Responses to Trauma in Adults. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780195399066.013.0006
40. Biswas, S., Raju, N. S. G., & Patel, K. R. (2015). Should Non-psychiatrists Be Trained to Recognize and Treat Co-morbid Depression?. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)31023-3
41. Bitnun, A., & Richardson, S. E. (2015). Childhood Encephalitis in Canada in 2015. Canadian Journal of Infectious Diseases and Medical Microbiology. https://doi.org/10.1155/2015/947602
42. Blanco, C., & Bernardi, S. (2014). Gambling Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg62
43. Bland, P. (2012). Tackling anxiety and depression in older people in primary care.. PubMed.
44. Blazer, D. G., & Hybels, C. F. (2005). Origins of depression in later life. Psychological Medicine. https://doi.org/10.1017/s0033291705004411
45. Boeft, M. D., Dessel, N. C.-V., & Wouden, J. C. V. D. (2017). How should we manage adults with persistent unexplained physical symptoms?. BMJ. https://doi.org/10.1136/bmj.j268
46. Bolton, E., Holohan, D. R., King, L. A., & King, D. W. (2004). Acute and Post-Traumatic Stress Disorder. Routledge eBooks. https://doi.org/10.4324/9780203336960-13
47. Bonevski, D., & Naumovska, A. (2018). Trauma and Anxiety Disorders throughout lifespan: Fear and anxiety from normality to disorder.. PubMed.
48. Bothwell, R. (2003). Cognitive behaviour therapy for psychosomatic disorders : main topic. CME: Your SA Journal of CPD.
49. Bouras, G., & Lazaratou, E. (2012). [Emergence of early childhood trauma in adult psychiatric symptomatology].. PubMed.
50. Boyd, R. (2022). What is a ‘Social Problem’ in Geriatrics?. Routledge eBooks. https://doi.org/10.4324/9781003284918-12
51. Boylan, K., & Eppel, A. (2008). The severe mood dysregulation phenotype: case description of a female adolescent.. PubMed.
52. Brandish, E. K., & Baldwin, D. S. (2012). Anxiety disorders. Medicine. https://doi.org/10.1016/j.mpmed.2012.08.017
53. Bransfield, R. C., & Friedman, K. J. (2019). Differentiating Psychosomatic, Somatopsychic, Multisystem Illnesses and Medical Uncertainty. Healthcare. https://doi.org/10.3390/healthcare7040114
54. Brar, S. S. (2017). Unique Somatic Delusions in a Schizoaffective Patient. Journal of Psychiatry.
55. Brdiczka, P. (2014). Drugs Can Only Affect Symptoms. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2014.0489a
56. Brinkmann, B. H. (2021). Mental Disorder Issues in People.
57. Bromberger, J. T. (1998). Gender and Depression. https://doi.org/10.1093/oso/9780195113969.003.0003
58. Bromberger, J. T., & Woods, N. F. (2009). Nonhormonal Factors Associated with Psychiatric Morbidity during the Menopausal Transition and Midlife. Key issues in mental health (Online)/Key issues in mental health (Print). https://doi.org/10.1159/000209601
59. Brooks, C. N., Talmage, J. B., & Mueller, K. L. (2012). Subjective, Objective, or Both?. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2012.marapr02
60. Brown, H. E., Stoklosa, J., & Freudenreich, O. (2012). How to Stabilize an Acutely Psychotic Patient: In Psychiatric Emergencies, Use a Stepwise Approach to Provide Safe, Effective Treatment. Current psychiatry.
61. Buckley, P., & Foster, A. (2014). Schizophrenia. https://doi.org/10.1007/978-3-7091-0715-7_4
62. Bukhari, S. N. A. (2022). Consequences of Antipsychotic Medications on Mental Health. Current Drug Safety. https://doi.org/10.2174/1574886317666220216101106
63. Buljan, D. (2009). Psychological and psychiatric factors of chronic pain.
64. Bulling, D., & Abdel‐Monem, T. (2009). Disaster Mental Health. Wiley Encyclopedia of Forensic Science. https://doi.org/10.1002/9780470061589.fsa476
65. Bulling, D., & Abdel‐Monem, T. (2012). Disaster Mental Health. Wiley Encyclopedia of Forensic Science. https://doi.org/10.1002/9780470061589.fsa476.pub2
66. Busse, J. W. (2007). The Neuroendocrinology of Medically Unexplained Syndromes. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-008-9_23
67. Bénony, H., Bénony-Viodé, C., & Dumas, J. (2012). Les troubles de l'humeur. Le point sur... Psychologie.
68. Büki, B., & Tarnutzer, A. A. (2013). History of complaints as a diagnostic tool. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199680627.003.0004
69. Băcilă, C., Anghel, C. E., & Vulea, D. (2019). Ethical aspects in the management of postpartum depression. Sæculum. https://doi.org/10.2478/saec-2019-0022
70. Cadoret, R. J. (1976). The genetics of affective disorder and genetic counseling. Social Biology. https://doi.org/10.1080/19485565.1976.9988217
71. Cadoret, R. J., & Winokur, G. (1972). Genetic Principles in the Classification of Affective Illnesses. International Journal of Mental Health. https://doi.org/10.1080/00207411.1972.11448572
72. Campling, F., & Sharpe, M. (2006). Getting Psychological Help. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198528821.003.0023
73. Campling, F., & Sharpe, M. (2006). Managing Severe Anxiety, Panic or Depression. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198528821.003.0022
74. Cao, F., Salem, H., Nagpal, C., & Teixeira, A. L. (2017). Prolonged delirium misdiagnosed as a mood disorder. Dementia & Neuropsychologia. https://doi.org/10.1590/1980-57642016dn11-020014
75. Capaldi, D. M., & Kim, H. K. (2014). Comorbidity of Depression and Conduct Disorder. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199797004.013.015
76. Caplan, R., Bursch, B., & Leipzig, A. (2012). Somatization. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199843824.003.0079
77. Carey, W. B. (1969). Psychologic Sequelae of Early, Infancy Health Crises. Clinical Pediatrics. https://doi.org/10.1177/000992286900800809
78. Carod-Artal, F. J., Irimia, P., & Ezpeleta, D. (2012). Migraña crónica: definición, epidemiología, factores de riesgo y tratamiento. Revista de Neurología. https://doi.org/10.33588/rn.5410.2012170
79. Casale, R., Sarzi‐Puttini, P., Botto, R., Alciati, A., Batticciotto, A., Marotto, D., & Torta, R. (2019). Fibromyalgia and the concept of resilience.. PubMed.
80. Casanova, Y. C., Torres, M. N., Ramírez, M. D. L., Ferrer, A. B., Calvo, R. N., & Ramos, I. J. (2021). Plan de cuidados de enfermería para paciente con deterioro de la movilidad.. Revista Sanitaria de Investigación.
81. Catheline, N. (2005). [Academic problems and school failure in adolescence].. PubMed.
82. Cha, Y., Baloh, R. W., Cho, C., Magnusson, M., Song, J., Strupp, M., Wuyts, F. L., & Staab, J. P. (2020). Mal de débarquement syndrome diagnostic criteria: Consensus document of the Classification Committee of the Bárány Society. Journal of Vestibular Research. https://doi.org/10.3233/ves-200714
83. Chaijan, P. Y., Salehi, B., Khosrobeigi, A., Hajirahimi, M., Rafiei, M., & Ahmadi, H. T. (2014). Prevalence of Obsessive-Compulsive Disorder in Pediatric Patients with the Daytime Frequency Syndrome of Childhood or Pollakiuria. Journal of Arak University of Medical Sciences.
84. Chakma, P., & Goswami, H. (2021). Burden &amp; Coping in Caregivers of Persons with Dementia. Eastern Journal of Psychiatry. https://doi.org/10.5005/ejp-19-1-18
85. Challacombe, F., & Wroe, A. L. (2013). A hidden problem: consequences of the misdiagnosis of perinatal obsessive–compulsive disorder. British Journal of General Practice. https://doi.org/10.3399/bjgp13x667376
86. Chen, D., & LaFrance, W. C. (2018). Epilepsy and Seizures. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615372423.sy10
87. Chen, Y.-S. (2012). Association between chronic insomnia and depression in elderly adults. Journal of the Chinese Medical Association. https://doi.org/10.1016/j.jcma.2012.04.001
88. Chiliza, B., & Vythilingum, B. (2011). Consultation liaison psychiatry in Africa – essential service or unaffordable luxury?. African Journal of Psychiatry. https://doi.org/10.4314/ajpsy.v14i4.1
89. Cho, C. (2005). Clinical Implications of Aging and Characteristics of Illnesses of the Aged. Journal of the Korean Medical Association. https://doi.org/10.5124/jkma.2005.48.1.15
90. Chouliaras, L., Topiwala, A., Cristescu, T., & Ebmeier, K. P. (2015). Establishing the cause of memory loss in older people.. PubMed.
91. Clarizio, H. F. (1989). Continuity in childhood depression.. PubMed.
92. Clarke, S., Murphy, B., Hester, R., & Jackson, A. C. (2022). How does illness uncertainty impact recovery among patients with cardiac conditions?. British Journal of Cardiac Nursing. https://doi.org/10.12968/bjca.2022.0102
93. Coccolini, F., Improta, M., Picetti, E., Vergano, L. B., Catena, F., Angelis, N. D., Bertolucci, A., Kirkpatrick, A. W., Sartelli, M., Fugazzola, P., Tartaglia, D., & Chiarugi, M. (2020). Timing of surgical intervention for compartment syndrome in different body region: systematic review of the literature. World Journal of Emergency Surgery. https://doi.org/10.1186/s13017-020-00339-8
94. Coghill, D., Bonnar, S., Duke, S., Graham, J., & Seth, S. (2009). Obsessive compulsive disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199234998.003.0020
95. Cohen, B. J. (2003). Personality Disorders. https://doi.org/10.1093/oso/9780195149371.003.0010
96. Copeland‐Linder, N., Onigu-Otite, E., Serico, J. M., Jamora, M., & Belcher, H. M. E. (2017). Neurobiology of Child Maltreatment and Psychological Trauma. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199937837.003.0181
97. Coronado, L. M. Q., Florez, D. A. C., & Tarazona, M. C. L. (2017). Prevalencia depresión en estudiantes universitarios Bucaramanga 2017.
98. Costa, E. G., Elizio, G., Raimundo, J., Fajardo, L., & Abreu-Freire, N. D. S. (2022). Analgesia não medicamentosa no processo de parturição: revisão sistemática da literatura. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.13
99. Cruz, M. C. D., Camargo, R. P. D., Cruz, L. C. D., Schiefelbein, N., Cruz, D. M. D., & Cruz, M. C. C. D. (2020). Migrânea: revisão de literatura. ARCHIVES OF HEALTH INVESTIGATION. https://doi.org/10.21270/archi.v10i2.4670
100. Császár, N. (2014). The Importance of Psychological Assessment and Support in Patients Suffering from Cardiovascular Disease or Undergoing Cardiac Treatment. Journal of Cardiovascular Diseases & Diagnosis. https://doi.org/10.4172/2329-9517.1000161
101. Cui, Y., Li, L., Chen, S., Zhao, Q., Li, L., & Gu, Z. (2017). AB0513 Fatigue in chinese patients with primary sjÖgren's syndrome: a cross sectional study. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2017-eular.3076
102. Cukor, D., Donahue, S., Tummalapalli, S. L., Bohmart, A., & Silberzweig, J. (2022). Anxiety, Comorbid Depression, and Dialysis Symptom Burden. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.01210122
103. Culpepper, L. (2006). Social anxiety disorder in the primary care setting.. PubMed.
104. Curto, M. P. M., & Quintana, M. V. M. (2009). [Co-morbility during depression].. PubMed.
105. Czajkowska‐Malinowska, M., & Cofta, S. (2014). Obturacyjny bezdech senny i jego społeczne następstwa.
106. Călin, A. M., Debita, M., Ciurcanu, O. E., Scutariu, M. M., & Szalontay, A. S. (2017). Xerostomia and Hyposalivation in Patients with Physical and Psychological Disabilities. Revista de Chimie. https://doi.org/10.37358/rc.17.10.5902
107. Dadsetan, P., Lazarus, R. S., & Jahangiri, H. (2019). Stress: Treatment, and Management. LAP LAMBERT Academic Publishing eBooks.
108. Dahlem, M. A., Mair, T., & Müller, S. C. (2004). Spatio-Temporal Aspects of a Dynamical Disease: Waves of Spreading Depression. Birkhäuser Basel eBooks. https://doi.org/10.1007/978-3-0348-7895-1_42
109. Dalal, S., Fabbro, E. D., & Bruera, É. (2006). Symptom Control in Palliative Care—Part I: Oncology as a Paradigmatic Example. Journal of Palliative Medicine. https://doi.org/10.1089/jpm.2006.9.391
110. Das, C., & Joseph, S. (2005). Falls in elderly.. PubMed.
111. Datta, K. (2022). Does the Patient Have Pain, Headaches, High Blood Pressure, Diabetes, Stroke, Ventilation or Cardiac Disorders, or Other Problems?. CRC Press eBooks. https://doi.org/10.1201/9781003093381-12
112. Debiais, S., Bonnaud, I., Ferreira-Maldent, N., Mercier, E., & Toffol, B. D. (2009). NEUROPSYCHIATRIC DISORDERS REVEALING PRIMARY ANTIPHOSPHOLIPID SYNDROME IN AN ELDERLY PATIENT. Neurology. https://doi.org/10.1212/wnl.0b013e3181a0fd69
113. Dedic, N., Sandra, M., & Jan (2011). Mouse Models of Depression. InTech eBooks. https://doi.org/10.5772/27498
114. Dembert, M. L. (1986). Sick Santa Syndrome. JAMA. https://doi.org/10.1001/jama.1986.03380230040016
115. Derbyshire, S., & Bremner, J. D. (2009). Impact Of Functional Visceral And Somatic Pain/Stress Syndromes On Cingulate Cortex. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198566960.003.0023
116. Deses, C. D. D. L. (2018). Alteraciones del sueño en personas adultas mayores. Revista de la Facultad de Medicina (México).
117. Dhobe, S., Gujar, S., & Sc, M. (2021). Prevalence of Associated Factors of Depressive Symptoms among School Going Children’s. Indian Journal of Forensic Medicine & Toxicology. https://doi.org/10.37506/ijfmt.v15i1.13470
118. Diefenbach, G. J., & Goethe, J. W. (2006). Clinical interventions for late-life anxious depression. Clinical Interventions in Aging. https://doi.org/10.2147/ciia.2006.1.1.41
119. Domínguez, M. R., Burgos, L. M., & Bergink, V. (2020). Perinatal Mood and Anxiety Disorders. Obstetrics and gynecology.. https://doi.org/10.1002/9781119450047.ch16
120. Donaghy, M., & Rossor, M. N. (2011). Psychologically determined disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198569381.003.0153
121. Douglas, M. E., Kim, B., Mayer, G., Crosby, B., & Towe-Goodm, N. (2012). Maternal Depression, Mothering and Child Development. InTech eBooks. https://doi.org/10.5772/38048
122. Dragoș, D., & Tănăsescu (2009). The critical role of psychosomatics in promoting a new perspective upon health and disease.. Journal of Medicine and Life.
123. Dragoș, D., Ionescu, O.-P., Micuţ, R., Ojog, D. G., & Tănăsescu, M. D. (2012). Psychoemotional features of a doubtful disorder: functional dyspepsia.. PubMed.
124. Dreyer-Oren, S. E., Mitnaul, L., & Holtzheimer, P. E. (2018). Mood Disorders. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615372423.sy25
125. Dudek, D., & Sobański, J. A. (2012). Mental disorders in somatic diseases: psychopathology and treatment. Polskie Archiwum Medycyny Wewnętrznej. https://doi.org/10.20452/pamw.1539
126. Duffy, A., Jones, S., Goodday, S., & Bentall, R. P. (2015). Candidate Risks Indicators for Bipolar Disorder: Early Intervention Opportunities in High-Risk Youth. The International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyv071
127. Duletic, N., Mijatovic-Papic, T., Cizmovic, B., & Kusturica, S. (2015). Differential Diagnostic Consideration of the Syndrome of Psychomotor Agitation in Geriatric Population. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)31130-5
128. Duntley, S. P. (2004). Insomnia in Primary Sleep Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-662-1_12
129. Duntley, S. P. (2004). Sleep State Misperception. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-662-1_8
130. Durand, B. (2003). [Psychological disorders in pregnancy].. PubMed.
131. Dwyer, A., Smith, N., & Quinton, R. (2019). Psychological Aspects of Congenital Hypogonadotropic Hypogonadism. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2019.00353
132. Dziegielewski, S. F. (2014). Depressive Disorders. https://doi.org/10.1002/9781394260577.ch7
133. Dünner, D. L. (2001). Management of anxiety disorders: The added challenge of comorbidity. Depression and Anxiety. https://doi.org/10.1002/da.1018
134. Dılbaz, N., & Enez, A. (2013). Treatment of Generalized Anxiety Disorders: Unmet Needs. InTech eBooks. https://doi.org/10.5772/53453
135. D’cruz, M., Andrade, C., & Rao, T. S. (2020). The Expression of Intimacy and Sexuality in Persons With Dementia. Journal of Psychosexual Health. https://doi.org/10.1177/2631831820972859
136. Egan, J., & Kenny, M. (2011). Somatization Disorder: What Clinicians Need to Know.
137. Ekuri, P., & Edim, M. E. (2014). Relevance of Physical Activity in the Treatment and Prevention of Mild and Severe Mental Health Problems. Studies in sociology of science. https://doi.org/10.3968/4442
138. El-Radhi, A. S. (2015). Management of common behaviour and mental health problems. British Journal of Nursing. https://doi.org/10.12968/bjon.2015.24.11.586
139. Elena, M. J. S. (2014). Influencia de los estilos de personalidad y de afrontamiento en la satisfacción con la vida de personas con enfermedades crónicas, insuficiencia renal crónica, artritis reumatoide y espondilitis anquilosante.
140. Ellgring, J. H. (1999). Depression, psychosis, and dementia: impact on the family.. PubMed.
141. Emmett, S. R., Hill, N. A., & Dajas‐Bailador, F. (2019). Psychiatry. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199694938.003.0018
142. Enrique, P. M. L., Gloria, A. S., Efraín, S. C. J., & Luis, G. A. J. (2019). Latencia diagnóstica en la enfermedad de Parkinson y su relación con los síntomas prodrómicos motores y no motores. eNeurobiología.
143. Ensalada, L. H., Brigham, C. R., & Kertay, L. (2018). Somatization. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2018.julaug03
144. Epel, E. S., McEwen, B. S., & Ickovics, J. R. (1998). Embodying Psychological Thriving: Physical Thriving in Response to Stress. Journal of Social Issues. https://doi.org/10.1111/j.1540-4560.1998.tb01220.x
145. Ernest, S., & Kuntz, H. M. (2020). Emergency department management of eating disorder complications in pediatric patients. PubMed.
146. Esquiliano, G. R., Ramírez, I. M., Valdés, A. T., & Aguilar, C. A. T. (2004). Daño neurológico secundario a hipoxia isquemia perinatal. Archivos de neurociencias (México, D.F.).
147. Evans, M., Copeland, J. R. M., & Dewey, M. (1991). Depression in the elderly in the community: Effect of physical illness and selected social factors. International Journal of Geriatric Psychiatry. https://doi.org/10.1002/gps.930061106
148. Eytan, A., & Loutan, L. (2006). Travel and psychiatric problems.
149. Falcão, F. A., Santos, A. L. D., Barbosa, D. C. B., & Santos, T. R. D. (2022). Responsabilidade civil no erro médico e dano moral. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.25
150. Fang, X., Patel, C., & Gudesblatt, M. (2020). Multiple Sclerosis. Obstetrics and Gynecology. https://doi.org/10.1097/aog.0000000000003727
151. Faravelli, C., Castellini, G., Fioravanti, G., Sauro, C. L., Pietrini, F., Lelli, L., Rotella, F., & Ricca, V. (2014). Different Childhood Adversities Are Associated with Different Symptom Patterns in Adulthood. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000363111
152. Fazel, M., Reed, R. V., & Goldring, L. (2012). Post-traumatic stress disorder. BMJ. https://doi.org/10.1136/bmj.e3790
153. Ferguson, E., & Cassaday, H. J. (2001). Theoretical Accounts of Gulf War Syndrome: From Environmental Toxins to Psychoneuroimmunology and Neurodegeneration. Behavioural Neurology. https://doi.org/10.1155/2002/418758
154. Fernández, A. A., Martín, Á. P., Martínez, M. I., Bustillo, M. A., Hernández, F. B., Labrado, J. D. L. C., Peñas, R. D.-D., Rivas, E. G., Delgado, C. P., Redondo, J. R., & Giménez, J. R. R. (2009). Chronic fatigue syndrome: aetiology, diagnosis and treatment. BMC Psychiatry. https://doi.org/10.1186/1471-244x-9-s1-s1
155. Fiebai, P. O., Ukueku, A. O., & Ogu, R. (2019). Pre Menstrual Syndrome. IntechOpen eBooks. https://doi.org/10.5772/intechopen.80492
156. Filipenka, H. (2021). Major depressive disorder..
157. Fink, P. (2012). Somatization disorder and related disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0129
158. Fischer, T., Agar, M., Hosie, A., & Teodorczuk, A. (2020). Unpacking agitation in practice: a call for greater precision. Age and Ageing. https://doi.org/10.1093/ageing/afaa110
159. Fisher, A. D., Bandini, E., Casale, H., & Maggi, M. (2011). Paraphilic Disorders: Diagnosis and Treatment. https://doi.org/10.1002/9781119963820.ch8
160. Fisher, R. L. (2022). Premenstrual Syndrome (PMS). CRC Press eBooks. https://doi.org/10.1201/9781003039235-42
161. Fonseca, R. S. D., Nazaré, G. O. D., Silva, P. S. L. D., Fortes, G. N., & Lemos, A. L. (2017). SINTOMAS DEPRESSIVOS EM ACADÊMICOS DE UMA UNIVERSIDADE PÚBLICA NO OESTE DO ESTADO DO PARÁ, RELATO DE EXPERIÊNCIA. 13º Congresso Internacional Rede Unida.
162. Fossey, M. E. (2011). Sleep Quality and Psychological Adjustment. LAP LAMBERT Academic Publishing eBooks.
163. Frankenburg, F. R., & Zanarini, M. C. (2006). Personality disorders and medical comorbidity. Current Opinion in Psychiatry. https://doi.org/10.1097/01.yco.0000228766.33356.44
164. Freeman, D., & Freeman, J. (2012). 10. Post-traumatic stress disorder. Anxiety. https://doi.org/10.1093/actrade/9780199567157.003.0010
165. Freeman, D., & Freeman, J. (2012). 7. Panic disorder. Anxiety. https://doi.org/10.1093/actrade/9780199567157.003.0007
166. Frieling-Sonnenberg, W. (1997). -At an age when patients need help, illness is promoted by the structures of geriatric care.. PubMed.
167. Fuchs, T. (1992). [The hypochondriacal delusion].. PubMed.
168. Galvez-Sánchez, C. M., & Paso, G. A. R. D. (2020). Affect and Personality in Fibromyalgia. https://doi.org/10.32545/encyclopedia202007.0018.v3
169. Galvez-Sánchez, C. M., Coba, P. D. L., Duschek, S., & Paso, G. A. R. D. (2020). Fibromyalgia Symptoms Overview. https://doi.org/10.32545/encyclopedia202009.0002.v2
170. Galvez-Sánchez, C. M., Duschek, S., & Paso, G. A. R. D. (2019). &lt;p&gt;Psychological impact of fibromyalgia: current perspectives&lt;/p&gt;. Psychology Research and Behavior Management. https://doi.org/10.2147/prbm.s178240
171. Garrabé, J., & Cousin, F. (2012). Acute and transient psychotic disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0081
172. Gautam, S., Jain, A., Gautam, M., Vahia, V., & Gautam, A. (2017). Clinical Practice Guidelines for the Management of Generalised Anxiety Disorder (GAD) and Panic Disorder (PD). Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.196975
173. Genazzani, A. D., Ricchieri, F., Lanzoni, C., Strucchi, C., & Jasonni, V. M. (2006). Diagnostic and Therapeutic Approach to Hypothalamic Amenorrhea. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1365.009
174. Gentile, J. P. (2018). Aggression in Intellectual Disability. International Journal of Autism & Related Disabilities. https://doi.org/10.29011/2642-3227.000010
175. Gerc, K., & Makiełło-Jarzowa, G. (1998). [Psychological consequences of neurologic motor impairment from a developmental perspective].. PubMed.
176. Ghoneim, M. M., & Block, R. I. (2012). Clinical, methodological and theoretical issues in the assessment of cognition after anaesthesia and surgery. European Journal of Anaesthesiology. https://doi.org/10.1097/eja.0b013e328356bd6e
177. Giannoglou, G. D., & Koskinas, K. C. (2014). Mental Stress and Cardiovascular Disease. Angiology. https://doi.org/10.1177/0003319714525032
178. Gill, C. E., & Kompoliti, K. (2019). Clinical Features of Tourette Syndrome. Journal of Child Neurology. https://doi.org/10.1177/0883073819877335
179. Gillen, M., Rose, E., & Schwarze, J. (2014). Conduct Disorder. https://doi.org/10.63134/nbfb7032
180. Ginting, D. A., Jayady, A., Habibi, M. M., Andarmoyo, S., & Irawan, A. (2020). Mental health problems in covid-19 situation. European Journal of Molecular & Clinical Medicine.
181. Glasper, E. A., McEwing, G., & Richardson, J. M. (2011). Chapter 13 Mental health problems. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199547197.003.0075
182. Goodwin, G. M. (2006). Depression and associated physical diseases and symptoms. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2006.8.2/mgoodwin
183. Gordon, M., & Melvin, G. (2014). Prescribing for depressed adolescents: Office decision-making in the face of limited research evidence. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.12517
184. Grant, I., Sacktor, N., & McArthur, J. C. (2005). HIV neurocognitive disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198526100.003.0035
185. Guerdjikova, A. I., McElroy, S. L., Barger, S. D., Barth, J., Farrelly, S., & Brohan, E. (2019). Recent Advances in Depressive Disorder.
186. Gulia, K. K., & Kumar, V. M. (2018). Sleep disorders in the elderly: a growing challenge. Psychogeriatrics. https://doi.org/10.1111/psyg.12319
187. Gupta, K., & Mamidi, P. (2022). Madonmada of Bhela samhita. Journal of Applied Consciousness Studies. https://doi.org/10.4103/ijoyppp.ijoyppp_16_21
188. Gutiérrez-Achury, A. M., Vanegas-Vidal, M., Salazar-Díaz, L. I., & Arías, G. M. A. (2009). Factores farmacológicos y no farmacológicos que afectan la adherencia al tratamiento de los pacientes esquizofrénicos dados de alta en la Unidad de Salud Mental del Hospital Universitario de Neiva entre enero y junio del 2008. RFS Revista Facultad de Salud. https://doi.org/10.25054/rfs.v1i2.43
189. Gutton, P. (1980). [Adolescence and acting (author's transl)].. PubMed.
190. Guy, A., Brown, M., Lewis, S., & Horowitz, M. (2020). The ‘patient voice’: patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition. Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125320967183
191. Guzé, S. B. (1952). CHRONIC PSYCHOGENIC HYPERVENTILATION. Archives of Neurology And Psychiatry. https://doi.org/10.1001/archneurpsyc.1952.02320160018002
192. Gómez‐Revuelta, M., Blanco, L. S., Ruíz, M. J., Jenaro, G. P. D. S., Rodríguez, R. L., Olivares, O. P., & Morales, N. N. (2017). A Clinical review about differential diagnosis and comorbidities on premenstrual dysphoric disorder. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.577
193. Gücüyener, K. (2012). 173 Clues for the Neurodevelopmental Prognosis of the High Risk Preterm and Term Newborns. Archives of Disease in Childhood. https://doi.org/10.1136/archdischild-2012-302724.0173
194. Haass, M., & Albus, C. (2014). Psychosoziale Faktoren bei Herzinsuffizienz: Mehr als eine Komorbidität?. Kardiologie up2date. https://doi.org/10.1055/s-0034-1365137
195. Hagberg, M. (1996). ABC of Work Related Disorders: Neck and arm disorders. BMJ. https://doi.org/10.1136/bmj.313.7054.419
196. Hakan, M., & Kemal, A. R. (2009). Sporcularda Durumluk ve Sürekli Kaygi Düzeylerinin Bazi Değişkenlere Göre İncelenmesi Examxination Of The Level Of State - Trial Anxiety Of Sportsmen According To Some Variables.
197. Halligan, S. L. (2014). Neurobiological outcomes in the offspring of postnatally depressed mothers: Causes and consequences. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199676859.003.0019
198. Hamaker, M. E., Bos, F. V. D., & Rostoft, S. (2020). Frailty and palliative care. BMJ Supportive & Palliative Care. https://doi.org/10.1136/bmjspcare-2020-002253
199. Hammett, E., Fernandez-Carbonell, C., Crayne, C. B., Boneparth, A., Cron, R. Q., & Radhakrishna, S. M. (2020). Adolescent Sjogren’s syndrome presenting as psychosis: a case series. Pediatric Rheumatology. https://doi.org/10.1186/s12969-020-0412-8
200. Hartanto, H., Hartono, B., & Nathawira, K. M. (2022). Sikap Berdiri Lama Dalam Menimbulkan Nyeri Punggung Bawah. Jurnal MedScientiae. https://doi.org/10.36452/jmedscientiae.v1i2.2661
201. Hartman, T. O., Lam, C. L. K., Usta, J., Clarke, D. D., Fortes, S., & Dowrick, C. (2018). Addressing the needs of patients with medically unexplained symptoms: 10 key messages. British Journal of General Practice. https://doi.org/10.3399/bjgp18x698813
202. Harwood, R., & Enguell, H. (2019). End-of-life care for frail older people. BMJ Supportive & Palliative Care. https://doi.org/10.1136/bmjspcare-2019-001953
203. Hasselt, F. M. V., Coehorst, Y., Verheijen-Breemhaar, D., Feenstra, B., & Loonen, A. (2014). [Hidden diseases: tuberculosis in a woman with a severe mental illness].. PubMed.
204. He, W., Shao, L., Wang, H., Huang, H., Zhang, S., Li, C., Zhang, C., & Yi, W. (2022). Bilateral Anterior Capsulotomy for the Treatment of Refractory Somatic Symptom Disorder: A Case Report. Frontiers in Integrative Neuroscience. https://doi.org/10.3389/fnint.2021.721833
205. Healey, S. E., Kales, A., Monroe, L. J., Bixler, E. O., Chamberlin, K., & Soldatos, C. R. (1981). Onset of Insomnia: Role of Life-Stress Events1. Psychosomatic Medicine. https://doi.org/10.1097/00006842-198110000-00007
206. Heinzer, R., Jordan, A. S., & Malhotra, A. (2006). Sleep Apnea Syndrome. Wiley Encyclopedia of Biomedical Engineering. https://doi.org/10.1002/9780471740360.ebs1097
207. Hellhammer, D. H., & Wade, S. E. (1993). Endocrine Correlates of Stress Vulnerability. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000288675
208. Henningsen, P. (2018). Somatic Symptom Disorder and Illness Anxiety Disorder. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615371990.jl11
209. Hernández, M., ESQUIVEL, N., & López, M. (2014). Fisiopatología, diagnóstico diferencial y tratamiento de la apnea emotiva grave: A propósito de un caso clínico. Revista chilena de pediatría. https://doi.org/10.4067/s0370-41062014000400012
210. Hildawati, H. (2021). PROBLEMATIKA GANGGUAN KECEMASAN PADA LANJUT USIA DI LINGKUNGAN SOSIAL. Moderasi Jurnal Studi Ilmu Pengetahuan Sosial. https://doi.org/10.24239/moderasi.vol2.iss2.41
211. Hollander, E., & Aronowitz, B. (1999). Comorbid social anxiety and body dysmorphic disorder: managing the complicated patient.. PubMed.
212. Holtzheimer, P. E., & Hamani, C. (2014). Deep brain stimulation for treatment-resistant depression. https://doi.org/10.2217/ebo.13.577
213. Hoon, D. (2012). Traumatic Experiences Disrupt Amygdala – Prefrontal Connectivity. InTech eBooks. https://doi.org/10.5772/48691
214. Hosey, M. M., & Bienvenu, O. J. (2021). Psychological Morbidity After Critical Illness. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780190077013.003.0005
215. House, J. S. (1987). Chronic stress and chronic disease in life and work: Conceptual and methodological issues. Work & Stress. https://doi.org/10.1080/02678378708258494
216. Hr, W. (1997). [Diagnosis and therapy of anxiety disorders].. PubMed.
217. Hybels, C. F., Blazer, D. G., & Steffens, D. C. (2006). Partial remission. A common outcome in older adults treated for major depression.. PubMed.
218. Häuser, W., Dinkel, A., & Lahmann, C. (2012). Funktionelle gastrointestinale Störungen. Psychiatrie und Psychotherapie up2date. https://doi.org/10.1055/s-0032-1304958
219. Hüfner, K., Sperner‐Unterweger, B., & Brugger, H. (2019). Going to Altitude with a Preexisting Psychiatric Condition. High Altitude Medicine & Biology. https://doi.org/10.1089/ham.2019.0020
220. Imran, N., Haider, I., & Azeem, M. W. (2017). Generalized Anxiety Disorder in Children and Adolescents: An Update. Psychiatric Annals. https://doi.org/10.3928/00485713-20170913-01
221. Iorga, M., Stârcea, I. M., Munteanu, M., & Sztankovszky, L.-Z. (2014). PSYCHOLOGICAL AND SOCIAL PROBLEMS OF CHILDREN WITH CHRONIC KIDNEY DISEASE.
222. Irgebaeva, N., & Akmusaeva, M. (2020). ANXIETY OF THE PERSONEMOTIONAL STATUS. BULLETIN Series Psychology. https://doi.org/10.51889/2020-3.1728-7847.04
223. Islam, M. T., Chowdhury, M. R., Snigdha, K. S. R., & Bhuiyan, M. S. I. (2014). Impact of Ankylosing Spondylitis on Paitents Work Status, Functional Disability and Quality of Life - A Review. BIRDEM Medical Journal. https://doi.org/10.3329/birdem.v4i2.33196
224. Ivada, P. F., Ardani, I. G. A. I., Lesmana, C. B. J., Windiani, I. G. A. T., Adnyana, I. G. A. N. S., & Fithriyah, I. (2022). Quality of life of pediatric patients experiencing organic depressive disorder with Juvenile Idiopathic Arthritis. International journal of health & medical sciences. https://doi.org/10.21744/ijhms.v5n4.1994
225. Jafferany, M., & Pastolero, P. (2018). Psychiatric and Psychological Impact of Chronic Skin Disease. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.17nr02247
226. Jain, S., Goel, S., & Kapila, S. (2015). Clinical Evaluation Of Psychiatric Emergencies.
227. James, T., & Somashekhar, L. M. (2021). Psychosis in Children and Young People. Child and Adolescent Mental Health. https://doi.org/10.4324/9781003083139-52
228. Jefferson, J. W. (2001). Social Anxiety Disorder. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.v03n0102
229. Jellinek, M. S., & Snyder, J. (1998). Depression and Suicide in Children and Adolescents. Pediatrics in Review. https://doi.org/10.1542/pir.19-8-255
230. Ji, J. (2012). Distinguishing subclinical (subthreshold) depression from the residual symptoms of major depression.. PubMed. https://doi.org/10.3969/j.issn.1002-0829.2012.05.007
231. Johnson, M. J., & Gozal, D. (2018). Vicarious breathlessness: an inferential perceptual learned transposition process that may not be inconsequential to either patient or caregiver. European Respiratory Journal. https://doi.org/10.1183/13993003.00306-2018
232. Johnston, S., Staines, Brenu, E., & Marshall-Gradisnik, S. (2014). Management of Chronic Fatigue Syndrome: Current Approaches and Future Directions. Nova Science Publishers eBooks.
233. Jones, W. E. (2021). What is the Most Widely RecognizedPsychological Illness Experienced by MoreSeasoned Grown-ups?. Clinical Psychiatry. https://doi.org/10.36648/2471-9854.7.1.79
234. Jorge, S. G., Higueras, P. H., & Correas-Lauffer, J. (2021). Illness anxiety disorder. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.684
235. Joshi, R., & Tomar, S. (2012). Effect of optimism/pessimism attitude on depression and coping strategies. Indian Journal of Positive Psychology. https://doi.org/10.15614/ijpp/2012/v3i4/53371
236. Joshi, S., & Kapur, J. (2012). GABAA Receptor Plasticity during Status Epilepticus. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199746545.003.0041
237. Juanes, R. G., Fuster, M. N. L., Gili, M., Bennasar, M. Á. R., & Toro, M. G. (2015). Estil de vida i salut mental. Anuari de l'envelliment: Illes Balears.
238. Juruena, M. F. (2012). Understanding subthreshold depression.. PubMed. https://doi.org/10.3969/j.issn.1002-0829.2012.05.009
239. Järvholm, S. (2022). [Psychological aspects of infertility].. PubMed.
240. Kakkar, R., & Teodorescu, M. (2011). Epidemiology of Sleep Disorders. BENTHAM SCIENCE PUBLISHERS eBooks. https://doi.org/10.2174/978160805153311101010014
241. Kalaiselvi, K. (2011). Level of depression and coping strategies among HIV clients.
242. Kanbara, K., & Fukunaga, M. (2009). Pathology of functional somatic syndrome.
243. Kancherla, N., Vanka, S. C., Pokhrel, S., Shahzadi, R. B., & Pradeep, G. V. D. (2022). The Development of Illness Anxiety Disorder in a Patient After Partial Thyroidectomy. Cureus. https://doi.org/10.7759/cureus.25416
244. Kanner, A. M., & Dunn, D. W. (2004). Diagnosis and Management of Depression and Psychosis in Children and Adolescents With Epilepsy. Journal of Child Neurology. https://doi.org/10.1177/088307380401900108
245. Kapfhammer, H. (2006). Somatic symptoms in depression. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2006.8.2/hpkapfhammer
246. Kapfhammer, H. (2011). [The relationship between depression, anxiety and heart disease - a psychosomatic challenge].. PubMed.
247. Kapfhammer, H. (2011). CS03-04 - Concept of somatoform disorder. European Psychiatry. https://doi.org/10.1016/s0924-9338(11)73481-2
248. Kapfhammer, H. (2018). ACUTE AND LONG-TERM MENTAL AND PHYSICAL SEQUELAE IN THE AFTERMATH OF TRAUMATIC EXPOSURE – SOME REMARKS ON “THE BODY KEEPS THE SCORE”. Psychiatria Danubina. https://doi.org/10.24869/psyd.2017.254
249. Kapfhammer, H. (2018). ACUTE AND LONG-TERM MENTAL AND PHYSICAL SEQUELAE IN THE AFTERMATH OF TRAUMATIC EXPOSURE – SOME REMARKS ON “THE BODY KEEPS THE SCORE”. Psychiatria Danubina. https://doi.org/10.24869/psyd.2018.254
250. Kar, S. K. (2015). Psychiatric aspects of pediatric epilepsy: Focus on anxiety disorder. Medical Journal of Dr D Y Patil University. https://doi.org/10.4103/0975-2870.160777
251. Kara, N. (2014). Cognitive Behavioral Therapy of a Generalized Anxiety Disorder Case Comorbid with Health Anxiety. Journal of Cognitive-Behavioral Psychotherapy and Research. https://doi.org/10.5455/jcbpr.158133
252. Karakatsoulis, G. N., Tsapakis, E.-M., & Fountoulakis, K. Ν. (2021). Clinical characteristics and treatment of treatment-resistant bipolar depression. Psychiatriki. https://doi.org/10.22365/jpsych.2021.048
253. Kasatkin, D. S. (2006). [Possible mechanisms of chronic fatigue syndrome in multiple sclerosis].. PubMed.
254. Katzman, M. A. (2021). The Diagnosis of Major Depressive Disorder is based on the Person's Reported Experiences and a Mental Status Examination. Journal of Aging and Geriatric Medicine.
255. Kavan, M., Elsasser, G. N., & Barone, E. J. (2009). Generalized anxiety disorder: practical assessment and management.. PubMed.
256. Kavan, M., Elsasser, G. N., & Barone, E. J. (2012). The physician's role in managing acute stress disorder.. PubMed.
257. Kelly, P. (2012). Posttraumatic Stress Disorder. Pediatrics in Review. https://doi.org/10.1542/pir.33.8.382
258. Kennedy, S. H. (2008). Core symptoms of major depressive disorder: relevance to diagnosis and treatment. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2008.10.3/shkennedy
259. Kessler, R. C., & Wang, P. S. (2008). The Descriptive Epidemiology of Commonly Occurring Mental Disorders in the United States. Annual Review of Public Health. https://doi.org/10.1146/annurev.publhealth.29.020907.090847
260. Ketterer, M. W., & Buckholtz, C. D. (1989). Somatization disorder.. PubMed.
261. Khademi, K., Dadkhah, A., & Kazemi, V. (2012). Body Part Concerns Questionnaire (BPCQ) in an Iranian Population with Special Needs. Iranian Rehabilitation Journal.
262. Khadse, V. S. C. (2022). Free Papers Compiled. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.341792
263. Kirshbaum, M. (2011). Pharmacologic Treatments for Fatigue Associated With Palliative Care. Clinical journal of oncology nursing. https://doi.org/10.1188/11.cjon.438-439
264. Kissane, D. W., & Yates, P. (2018). Psychological and Existential Distress. Routledge eBooks. https://doi.org/10.4324/9781315378473-16
265. Klipstein, A., & Nydegger, A. (2013). Rückenschmerzen im Erwerbstätigenalter. Therapeutische Umschau. https://doi.org/10.1024/0040-5930/a000440
266. Knapen, J., Vancampfort, D., Schoubs, B., Probst, M.-T., Sienaert, P., Haake, P., Peuskens, J., & Pieters, G. (2009). Exercise for the Treatment of Depression. The Open Complementary Medicine Journal. https://doi.org/10.2174/1876391x00901010078
267. Knüsel, H. (1993). [Emergency: the internist as psychiatrist].. PubMed.
268. Koo, S. K. (2018). Depression Status in Korea. Osong Public Health and Research Perspectives. https://doi.org/10.24171/j.phrp.2018.9.4.01
269. Korff, M. V., & Simon, G. (1996). The Relationship Between Pain and Depression. The British Journal of Psychiatry. https://doi.org/10.1192/s0007125000298474
270. Korhonen, T. K., MATIlLA-RAUTIAINEN, S., MARKKU, N., & TOSSAVAINEN, S. (2008). An Experimental Study Of The Effects Of Riding With Chronic Low Back Pain Patients. HETI Journal International Research and Practice. https://doi.org/10.58862/ojhx5336
271. Koroleva, E., & Kcharitonova, N. (2009). Specialty of Anxiety States in Elderly. European Psychiatry. https://doi.org/10.1016/s0924-9338(09)71065-x
272. Kotade, K. B., Pandit, B. S., Gaware, V. M., Dolas, R. T., Dhamak, K. B., Somwanshi, S. B., Nikam, V. K., & Khadse, A. N. (2011). KNOWING DEPRESSION AND PHARMACOLOGICAL, NON-PHARMACOLOGICAL APPROACHES FOR ITS TREATMENT.
273. Kouris, A., Platsidaki, E., KOUSKOUKIS, C. E., & Christodoulou, C. (2017). Psychological parameters of psoriasis. Psychiatriki. https://doi.org/10.22365/jpsych.2017.281.54
274. Krahn, L. E., MD, & Jowsey‐Gregoire, S. G. (2006). Psychiatry. CRC Press eBooks. https://doi.org/10.1201/b21610-26
275. Krause, C. K. (2022). “Everything Hurts and I’m Weak, Doc”. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197544464.003.0021
276. Kreek, M. J. (2011). Extreme marginalization: addiction and other mental health disorders, stigma, and imprisonment. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.2011.06152.x
277. Kroenke, K. (2011). Symptom management research in cancer patients: state of the art. BMJ Supportive & Palliative Care. https://doi.org/10.1136/bmjspcare-2011-000020.1
278. Krystal, A. D., Edinger, J. D., & Wohlgemuth, W. K. (2013). Sleep and Circadian Rhythm Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370016.mt08
279. Kumar, G. P., Krishna, P. Y., Manisha, D., Singh, G., Khushboo, A., & Ps, M. (2015). ROLE OF MANAS BHAVA IN THE ETIOPATHOGENESIS OF AMLAPITTA IN CONTEXT OF HYPERACIDITY.
280. Kučikienė, O., Lesauskaitė, V., Macijauskienė, J., Vainoras, A., Blaževičienė, A., Samėnienė, J., Alekna, V., Satkunskienė, D., Naudžiūnas, A., & Krutulytė, G. (2009). Dažniausi hospitalizuotų pagyvenusio amžiaus pacientų sveikatos sutrikimai.
281. Lam, R. W. (2018). Associated clinical features. Depression. https://doi.org/10.1093/med/9780198804147.003.0005
282. Landolfi, M., Parise, V. F., Balletta, G., & Manna, G. L. (2011). Recovery Versus Remission in Schizophrenia and Related Persistent Psychotic Disorders: no Contrasting but Complementary Models. European Psychiatry. https://doi.org/10.1016/s0924-9338(11)73091-7
283. Lang, A. E., & Voon, V. (2011). Psychogenic movement disorders: Past developments, current status, and future directions. Movement Disorders. https://doi.org/10.1002/mds.23571
284. LATHAM, M. (2006). Colin: A case of health anxiety. Routledge eBooks. https://doi.org/10.4324/9780203966037-23
285. Lauriat, T. L., & Samson, J. (2015). Endocrine Disorders Associated with Psychological/Behavioral Problems. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199352722.013.32
286. Lehrer, P. M., Feldman, J., Giardino, N. D., Song, H.-S., & Schmaling, K. B. (2002). Psychological aspects of asthma.. Journal of Consulting and Clinical Psychology. https://doi.org/10.1037//0022-006x.70.3.691
287. Lemke, M. K. (1996). Das chronische Erschöpfungssyndrom - psychiatrische Aspekte. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-2007-996379
288. Lemogne, C., Pitron, Jy, R., Limosin, F., & Cathébras, P. (2019). What attitude towards a patient with somatoform disorder?. PubMed.
289. Lepping, P., Huber, M., & Freudenmann, R. W. (2015). How to approach delusional infestation. BMJ. https://doi.org/10.1136/bmj.h1328
290. Li, M., Rosenblat, J. D., & Rodin, G. (2018). Depression. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615371990.jl07
291. Li, X., & Li, S. X. (2022). Paediatric Insomnia. https://doi.org/10.1007/978-981-19-5791-8_6
292. Linden, M. (2020). Euthymic suffering and wisdom psychology. World Psychiatry. https://doi.org/10.1002/wps.20718
293. ling, Z. G. (2014). 脑瘫患儿家长焦虑和抑郁状况及其影响因素的研究. Zhonghua wuli yixue zazhi. https://doi.org/10.3760/cma.j.issn.0254-1424.2014.03.004
294. Lipowski, Z. J. (1987). Somatization: The Experience and Communication of Psychological Distress as Somatic Symptoms. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000288013
295. Liptak, G. S. (1998). THE CHILD WHO HAS SEVERE NEUROLOGIC IMPAIRMENT. Pediatric Clinics of North America. https://doi.org/10.1016/s0031-3955(05)70586-1
296. Lockhart, P. J. (2001). Fetal alcohol spectrum disorders for mental health professionals - a brief review. Current Opinion in Psychiatry. https://doi.org/10.1097/00001504-200109000-00007
297. Looper, M. D., Lafortune, G., Balestat, G., Gool, K. V., Biondi, N., & Mueller, M. (2012). Suicide. Health at a glance. Europe. https://doi.org/10.1787/9789264183896-10-en
298. Loosen, P. T. (1994). Cushingʼs Syndrome and Depression. The Endocrinologist. https://doi.org/10.1097/00019616-199409000-00008
299. Lucassen, P., Ockenburg, S. V., Gans, R. O. B., Rosmalen, J. G., & Hartman, T. O. (2022). [Fatigue].. PubMed.
300. Lundh, L. (1987). Placebo, belief, and health. A cognitive–emotion model. Scandinavian Journal of Psychology. https://doi.org/10.1111/j.1467-9450.1987.tb00747.x
301. Lázaro, C. P., Pondé, M. P., & Rodrigues, L. E. A. (2014). SOME BIOCHEMICAL IMPLICATIONS IN AUTISM SPECTRUM DISORDER. Brazilian Journal of Medicine and Human Health. https://doi.org/10.17267/2317-3386bjmhh.v2i3.493
302. Lépine, J., & Pélissolo, A. (2000). Why take social anxiety disorder seriously?. Depression and Anxiety. https://doi.org/10.1002/(sici)1520-6394(2000)11:3<87::aid-da1>3.3.co;2-0
303. L�pine, J.-P., & P�lissolo, A. (2000). Why take social anxiety disorder seriously?. Depression and Anxiety. https://doi.org/10.1002/(sici)1520-6394(2000)11:3<87::aid-da1>3.0.co;2-9
304. Macovei, A. L., Dobrin, I., Chiriță, V., Burlui, A., Dobrin, P.-R., & Rezuş, E. (2019). Chronic fatigue and psychiatric comorbidities in patients with rheumatic disorders. Bulletin of Integrative Psychiatry. https://doi.org/10.36219/bpi.2019.03.08
305. Maestrelli, L. G., Martins-da-Silva, A. S., & Castaldelli-Maia, J. M. (2021). Depression in homeless. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198842668.003.0016
306. Mak, V., & Lubbe, S. (2015). Older adults. https://doi.org/10.1002/9781118557211.ch30
307. Mandos, L. A., PharmD, Reinhold, J. A., Bcps, Bcpp, & Rickels, K. (2009). Achieving Remission in Generalized Anxiety Disorder.
308. Manica, A., Leães, C. G. S., Frey, B. N., & Juruena, M. F. (1999). The role of depression in coronary artery disease. Arquivos Brasileiros de Cardiologia. https://doi.org/10.1590/s0066-782x1999000800012
309. Manniche, C., Hauge, E., Voss, A., Mašić, D., Johannsen, F. E., Johannsen, F. E., Voss, A., Mašić, D., Mašić, D., Voss, A., & Johannsen, F. E. (2018). Patient med rygsmerter. Research Portal Denmark.
310. Manschreck, T. C. (1996). Delusional disorder: the recognition and management of paranoia.. PubMed.
311. Maramis, M. M. (2009). Mengenal Gangguan Mood pada Perempuan.
312. Mardaga, S., Bassir, M. A., Bracke, J., Dutilleux, A., & Born, J. D. (2017). [Which psychiatric symptoms must raise suspicion about a possible brain tumor ?]. PubMed.
313. Margraf, J., Taylor, C. B., Ehlers, A., Roth, W. T., & Agras, W. S. (1987). Panic Attacks in the Natural Environmet. The Journal of Nervous and Mental Disease. https://doi.org/10.1097/00005053-198709000-00008
314. Marks, I., & Lader, M. (1973). ANXIETY STATES (ANXIETY NEUROSIS). The Journal of Nervous and Mental Disease. https://doi.org/10.1097/00005053-197301000-00001
315. Marneros, A., & Pillmann, F. (2004). Defining the brief, acute and transient psychotic disorders: the polymorphic psychotic core. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544002.012
316. Martin, P., & Poon, L. W. (2015). Exceptional Survivors. The Encyclopedia of Adulthood and Aging. https://doi.org/10.1002/9781118521373.wbeaa073
317. María, A., Sancho, R., & Pita, B. L. (2005). Trastornos de ansiedad en la infancia y en la adolescencia.
318. Mateen, Y., Lally, J., & Bokhari, S. Q. (2022). Chronic, Unipolar, Treatment-Resistant Mania: A Case Report and Literature Review. BJPsych Open. https://doi.org/10.1192/bjo.2022.363
319. Mateus, L. A. S. (2022). Games violentos e sua relação com comportamento social das crianças. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.19
320. Mauri, M., & Ramacciotti, D. (2006). Sintomi Psichici e Somatici dei Disturbi dell'Umore: razionali di terapia. Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology.
321. Mazzoni, P., Kimhy, D., Khan, S., Posner, K., Maayan, L., Eilenberg, M., Walsh‐Messinger, J., Kestenbaum, C. J., & Corcoran, C. M. (2009). Childhood Onset Diagnoses in a Case Series of Teens at Clinical High Risk for Psychosis. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2008.0105
322. McGorry, P. D., & Yung, A. R. (2020). Transition to adulthood. Routledge eBooks. https://doi.org/10.4324/9780429285806-2
323. McGuire, B. E., & Wraith, A. E. (2000). Legal and psychological aspects of stalking: a review. Journal of Forensic Psychiatry. https://doi.org/10.1080/09585180050142543
324. McIntyre, R. S., & Calabrese, J. R. (2019). Bipolar depression: the clinical characteristics and unmet needs of a complex disorder. Current Medical Research and Opinion. https://doi.org/10.1080/03007995.2019.1636017
325. McKnight, R., Price, J., & Geddes, J. (2019). Child and adolescent psychiatry: general aspects of care. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198754008.003.0024
326. McKnight, R., Price, J., & Geddes, J. (2019). Conducting the assessment: examining the patient. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198754008.003.0010
327. McKnight, R., Price, J., & Geddes, J. (2019). Medically unexplained physical symptoms. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198754008.003.0033
328. McKnight, R., Price, J., & Geddes, J. (2019). People presenting with physical disorder. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198754008.003.0027
329. McKnight, R., Price, J., & Geddes, J. (2019). Sleep disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198754008.003.0036
330. McManus, I. C., Stubbings, G. F., & Martín, N. P. D. C. (2006). Stigmatization, Physical Illness and Mental Health in Primary Ciliary Dyskinesia. Journal of Health Psychology. https://doi.org/10.1177/1359105306063320
331. McVicar, K. (2006). Seizure-like States. Pediatrics in Review. https://doi.org/10.1542/pir.27.5.e42
332. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). [Clinical practice guideline. Diagnosis and treatment of insomnia in the elderly].. PubMed.
333. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). Diagnóstico y tratamiento del insomnio en el adulto mayor.
334. Meeke, H. J. (2011). Hypochondriasis (Health Anxiety) Reformulated: Similarities With Generalized Anxiety Disorder in A Routine Setting Single Case.
335. Melca, I. A., & Fortes, S. (2014). Obesidade e transtornos mentais: construindo um cuidado efetivo Obesity and mental disorders: building an effective care.
336. Melca, I. A., & Fortes, S. (2014). Obesidade e transtornos mentais: construindo um cuidado efetivo. Revista Hospital Universitário Pedro Ernesto. https://doi.org/10.12957/rhupe.2014.9794
337. Mercer, S. W., Gunn, J., Bower, P., Wyke, S., & Guthrie, B. (2012). Managing patients with mental and physical multimorbidity. BMJ. https://doi.org/10.1136/bmj.e5559
338. Merlo, L. J., & Storch, E. A. (2006). Obsessive-compulsive disorder: tools for recognizing its many expressions.. PubMed.
339. Mervis, C. Β., Morris, C. A., Klein-Tasman, B., Velleman, S. L., & Osborne, L. R. (2015). 7q11.23 Duplication Syndrome.
340. Meyer, J. S., & Hamel, A. F. (2014). Models of Stress in Nonhuman Primates and Their Relevance for Human Psychopathology and Endocrine Dysfunction. ILAR Journal. https://doi.org/10.1093/ilar/ilu023
341. Michie, S. (2002). CAUSES AND MANAGEMENT OF STRESS AT WORK. Occupational and Environmental Medicine. https://doi.org/10.1136/oem.59.1.67
342. Micoulaud‐Franchi, J., Lemogne, C., & Quilès, C. (2019). [Definition of somatoform disorders: somatic symptoms or mental symptoms?]. PubMed.
343. Mikkelsen, M. E., & Iwashyna, T. J. (2020). Persistent problems and recovery after critical illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0395
344. Mikkelsen, M. E., & Iwashyna, T. J. (2020). Persistent problems and recovery after critical illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0395_update_001
345. Mills, S. (2015). Chronic low back pain. InnovAiT Education and inspiration for general practice. https://doi.org/10.1177/1755738015579209
346. Miléo, J. C., Andrade, P. C. D. S., & Connor, P. J. D. S. (2022). Repercussões da ansiedade em tempos de pandemia: papel do psicólogo e possíveis estratégias de manejo na saúde mental. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.22
347. Mineka, S., Luten, A. G., & Pury, C. L. S. (1991). Is Lack of Control Over Emotions, or Over Stressful Life Events, More Important in Disorders of Emotion?. Psychological Inquiry. https://doi.org/10.1207/s15327965pli0201_21
348. Mlakar, P., & Stare, J. (2014). Some Characteristics of Employees as Risk Factors for Presenteeism. Central European Public Administration Review. https://doi.org/10.17573/ipar.2013.2.a02
349. Montoya, A., & Alejandra, M. (2020). Estrés laboral y sus consecuencias en la salud que afectan el rendimiento.
350. Mott, T., McConnon, M. L., & Rieger, B. (2012). Subacute to chronic mild traumatic brain injury.. PubMed.
351. Motta, M. P., Quadros, A. A. J., Ferreira, L. S., & Oliveira, A. S. B. (2019). Fatigue in Post-Polio Syndrome. Brazilian Journal of Biological Sciences. https://doi.org/10.21472/bjbs.061203
352. Moura, G. S., Neves, L. M. T., Giorelli, A. S., Florido, P., & Gomes, M. D. M. (2013). Transtornos do sono: visão geral Sleep disorders: overview.
353. Moutzouris, D.-A., & Falagas, M. E. (2009). Interstitial Cystitis. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.02000309
354. Mulsant, B. H., & Ganguli, M. (1999). Epidemiology and diagnosis of depression in late life.. PubMed.
355. Munir, S., & Takov, V. (2021). Generalized Anxiety Disorder. StatPearls.
356. Munir, S., Takov, V., & Coletti, V. A. (2021). Generalized Anxiety Disorder (Nursing).
357. Muotri, R. W., Nunes, R. P., & Bernik, M. (2007). Exercício aeróbio como terapia de exposição a estímulos interoceptivos no tratamento do transtorno de pânico. Revista Brasileira de Medicina do Esporte. https://doi.org/10.1590/s1517-86922007000500009
358. Muskin, P. R. (2014). DSM-5 Self-Exam Questions: Test Questions for the Diagnostic Criteria.
359. Mut, E. A., Pălădoiu, C., & Stănescu, M. (2021). Somatoform and conversion disorders as psychological defences. Journal of Educational Sciences & Psychology. https://doi.org/10.51865/jesp.2021.1.19
360. Müller, A. (2020). Mental health disorders: prevalent but widely ignored in academia?. The Journal of Physiology. https://doi.org/10.1113/jp279386
361. Naeim, M. (2021). How to control stress caused by COVID-19?. Healthy Aging Research.
362. Naidoo, S. (2015). Managing stress in the dental environment.
363. Nanagas, M. T. (2011). Bipolar Disorders. Pediatrics in Review. https://doi.org/10.1542/pir.32.11.502
364. Nandi, K., Sarkar, S., Bakshi, P., Chandra, A. C., Chakraborty, A., Mondal, S., Biswas, A., Bera, K., Sen, D. J., & Saha, D. (2005). COVID-19 & CO-MORBIDITY: DEMONIC FORCES THAT SUPRESS THE CIVILIZATION. World Journal of Pharmaceutical and life sciences.
365. Nasrallah, H. A. (2009). Diagnosis 2.0 Are Mental Illnesses Diseases, Disorders, or Syndromes? A Major Challenge for the DSM-V Committees as They Revise the Diagnostic "Bible" of Psychiatric Disorders Is to Determine Whether Mental Illnesses Are Diseases, Disorders, or Syndromes. Current psychiatry.
366. Nasrallah, H. A. (2014). Borderline Personality Disorder Is a Heritable Brain Disease. Current psychiatry.
367. Neeleman, J., & Mh, D. G. (2006). [Suicidal tendencies, a disorder that crosses boundaries between disciplines].. PubMed.
368. Negro, A., Rocchietti-March, M., Fiorillo, M., & Martelletti, P. (2011). Chronic migraine: current concepts and ongoing treatments.. PubMed.
369. Ninan, P. T. (2001). Dissolving the burden of generalized anxiety disorder.. PubMed.
370. Ninan, P. T. (2001). Recent perspectives on the diagnosis and treatment of generalized anxiety disorder.. PubMed.
371. Nishino, S., & Fujiki, N. (2006). Animal models for sleep disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511541742.029
372. Noyes, R. (2014). Course and Outcome of Hypochondriasis and Health Anxiety. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199996865.003.0007
373. O'Donnell, R. M., & Kaszniak, A. W. (2011). Charting late-life affective disorders. Generations.
374. Okuniewska, A., Walczuk, B. I., Czubek, M., & Biernat, W. (2011). Recurrent Deep Ulcers Resembling Rare Cancers as a Form of Factitious Disorder. Acta Dermato Venereologica. https://doi.org/10.2340/00015555-1027
375. Olsson, S. (2015). Missnöjet pyr över svensk häktestortyr - En undersökning av det kritiserade häktningsinstitutet.
376. Olubusola, J. (2012). Therapeutic Exercises in the Management of Non-Specific Low Back Pain. InTech eBooks. https://doi.org/10.5772/35856
377. Ong, L. T. C., Galambos, G., & Brown, D. A. (2017). Primary Sjogren’s Syndrome Associated With Treatment-Resistant Obsessive–Compulsive Disorder. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2017.00124
378. Oster, C. (1976). Sensory Deprivation in Geriatric Patients. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.1976.tb03261.x
379. Otsuka, K., Kato, S., Abe, T., SUGIYAMA, H., Watanabe, Y., Kobayashi, T., & Okajima, Y. (2002). [Classification of long-term clinical course of 'atypical psychosis': a 20-year follow-up study at a medical school hospital].. PubMed.
380. Ownby, R. L. (2006). Medication adherence and cognition. Medical, personal and economic factors influence level of adherence in older adults.. PubMed.
381. Pachana, N. A., Laidlaw, K., Ceglowski, J., Dios, L. V. D., & Depp, C. A. (2014). Psychosis in Older Adults. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199663170.013.041
382. Page, A. (2004). Illness Narratives in Manic-Depressive Disorder: Issues of Self and Identity. University of Huddersfield eBooks.
383. Palmer, B. W., McClure, F. S., & Jeste, D. V. (2001). Schizophrenia in Late Life: Findings Challenge Traditional Concepts. Harvard Review of Psychiatry. https://doi.org/10.1080/10673220127883
384. Palmer, R. S. (1950). PSYCHE AND BLOOD PRESSURE. Journal of the American Medical Association. https://doi.org/10.1001/jama.1950.02920040009003
385. Pankov, V. A., Lakhman, О. L., & Kuleshova, M. V. (2020). Emotional burnout in medical workers during the work in extreme conditions. Hygiene and Sanitation. https://doi.org/10.47470/0016-9900-2020-99-10-1034-1041
386. Paradela, E. M. P. (2011). Depressão em idosos. Revista Hospital Universitário Pedro Ernesto (TÍTULO NÃO-CORRENTE). https://doi.org/10.12957/rhupe.2011.8850
387. Paredes, D. F. D., Farfán, J. C. P., Orellana, J. M. F., & Legarda, A. A. B. (2019). Trastorno disfórico premenstrual. RECIAMUC. https://doi.org/10.26820/reciamuc/3.(1).enero.2019.199-217
388. Park, J. S., Belfort, M. A., & Norwitz, E. R. (2001). Pathogenesis and treatment of eclampsia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511545634.030
389. Parkinson, J. T., Foley, É. M., Jadon, D. R., & Khandaker, G. M. (2020). Depression in patients with spondyloarthritis: prevalence, incidence, risk factors, mechanisms and management. Therapeutic Advances in Musculoskeletal Disease. https://doi.org/10.1177/1759720x20970028
390. Parmet, S., Burke, A. E., & Glass, R. M. (2006). Insomnia. JAMA. https://doi.org/10.1001/jama.295.24.2952
391. Parry, S., Lloyd, M., & Wilson, H. (2022). Using digital mediums to provice trauma-informed support to people with complex presentations. Jessica Kingsley Publishers eBooks.
392. Pathology, S.-L., Girten, D., & Lackey, C. (2014). Working with Children with Mental Health Issues.
393. Patten, S. B. (2015). Major depressive disorder: reification and (maybe) rheostasis. Epidemiology and Psychiatric Sciences. https://doi.org/10.1017/s2045796015000682
394. Patti, L., & Gupta, M. (2019). Change In Mental Status. StatPearls.
395. Pavone, P., Corsello, G., Ruggieri, M., Marino, S., Marino, S. D., & Falsaperla, R. (2018). Benign and severe early-life seizures: a round in the first year of life. The Italian Journal of Pediatrics/Italian journal of pediatrics. https://doi.org/10.1186/s13052-018-0491-z
396. Pegrum, S. N. (2009). Putting the pieces together: The subjective experience of anorexia nervosa over the course of the disorder. https://doi.org/10.4226/66/5a95ee1bc6804
397. Peixoto, C., Rêgo, D. C., Bicho, M., Coelho, J. M., & Medeiros, H. (2021). Delusional infestation: Two case reports. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.2034
398. Pennebaker, J. W. (1994). Psychological Bases of Symptom Reporting: Perceptual and Emotional Aspects of Chemical Sensitivity. Toxicology and Industrial Health. https://doi.org/10.1177/074823379401000519
399. Penninx, B. W., & Dyck, R. V. (2001). Depression and Somatic Comorbidity. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1080/0004867010060522
400. Pentin, P. L., & Sperry, L. D. (2015). Somatoform Disorders and Related Syndromes. Family Medicine. https://doi.org/10.1007/978-1-4939-0779-3_35-1
401. Pergolizzi, J. V., Passik, S. D., LeQuang, J. A., Colucci, D., Taylor, R., Raffa, R. B., & Bisney, J. (2018). The risk of suicide in chronic pain patients. Nursing and Palliative Care. https://doi.org/10.15761/npc.1000189
402. Perington, M. R., Smith, C. A., & Schillerstrom, J. E. (2019). Decisional Capacity and Personality Disorders: Substantially Unable or Substantially Unwilling?. Journal of Forensic Sciences. https://doi.org/10.1111/1556-4029.14219
403. Perrin, J. M., Gnanasekaran, S. K., & Delahaye, J. (2012). Psychological Aspects of Chronic Health Conditions. Pediatrics in Review. https://doi.org/10.1542/pir.33.3.99
404. Pervanidou, P., & Chrousos, G. P. (2018). Early-Life Stress: From Neuroendocrine Mechanisms to Stress-Related Disorders. Hormone Research in Paediatrics. https://doi.org/10.1159/000488468
405. Peterson, H. W., & Martin, M. (1973). Organic Disease Presenting as a Psychiatric Syndrome. Postgraduate Medicine. https://doi.org/10.1080/00325481.1973.11713534
406. Peyre, H., & Viorrain, M. (2018). [Pediatric Somatic Symptom Disorders].. PubMed.
407. Peña, D. A., Pérez, M. L., & Pinzón, L. F. C. (2014). Línea de investigación psicología clínica y de la salud..
408. Peña, M. A. M. (2013). Síndrome de sobreentrenamiento. IATREIA.
409. Phillips, K. A. (2014). Body Dysmorphic Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg22
410. Phillips, K. A. (2014). Body Dysmorphic Disorder: Common, Severe and in Need of Treatment Research. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000366035
411. Plaza-González, S., Zabala-Baños, M. D. C., Astasio-Picado, Á., & Jurado‐Palomo, J. (2022). Psychological and Sociocultural Determinants in Childhood Asthma Disease: Impact on Quality of Life. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph19052652
412. Poljak, T. H. (2018). "Alzheimer’s dementia ". Hospice and Palliative Medicine International Journal. https://doi.org/10.15406/hpmij.2018.02.00084
413. Pollack, M. H. (2001). Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder.. PubMed.
414. Pompili, M., Lamis, D. A., Andrasik, F., & Martelletti, P. (2020). Headache and psychiatry. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198724322.003.0052
415. Popović-Deušić, S., Lečić‐Toševski, D., Pejović-Milovančević, M., Draganić-Gajić, S., Aleksić-Hil, O., & Radosavljev-Kirćanski, J. (2011). Digeorge syndrome: A case report. Srpski arhiv za celokupno lekarstvo. https://doi.org/10.2298/sarh1110681p
416. Porcelli, P., Laera, D., Mastrangelo, D., & Masi, A. D. (2012). Prevalence of Allostatic Overload Syndrome in Patients with Chronic Cardiovascular Disease. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000341179
417. Powers, S. W., Gilman, D. K., & Hershey, A. D. (2006). Headache and Psychological Functioning in Children and Adolescents. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.2006.00583.x
418. Praško, J., Raszka, M., & Pastucha, P. (2009). Dissociative Disorders - Clinical Manifestation and Management. European Psychiatry. https://doi.org/10.1016/s0924-9338(09)70376-1
419. Pujalte, G. G., & Benjamin, H. J. (2018). Sleep and the Athlete. Current Sports Medicine Reports. https://doi.org/10.1249/jsr.0000000000000468
420. Pérez, Y. M. M., Ortega, D. L. G., & Torres, S. V. L. (2022). AGITACIÓN PSICOMOTRIZ. PUERTO MADERO EDITORIAL eBooks. https://doi.org/10.55204/pmea.3.c10
421. Qualls, S. H. (2002). Defining Mental Health in Later Life. Generations.
422. Qureshi, M. A., & Wasti, S. A. (2014). Lay-off Survivor Sickness Syndrome (Investigating the Lasting Impact on Performance of Survivors in the Context of Age and Gender in Private Sector Organizations of Pakistan). International Journal of Human Resource Studies. https://doi.org/10.5296/ijhrs.v4i3.6078
423. Racciatti, D., Barberio, A., Vecchiet, J., & Pizzigallo, E. (1999). Clinical and Pathogenetical Characterization of 238 Patients of a Chronic Fatigue Syndrome Italian Center. Journal of Chronic Fatigue Syndrome. https://doi.org/10.1300/j092v05n03_05
424. Rachmani, S., & Mayasari, D. (2017). Kombinasi Farmakoterapi dan Psikoterapi Pada Pengobatan Episode Depresif Sedang Dengan Gejala Somatis. Jurnal Medula.
425. Ramakrishnan, N., Bansal, A., & Ponnish, A. S. (2022). Practical approach to sleep disordered breathing. Indian Journal of Respiratory Care. https://doi.org/10.5005/jp-journals-11010-02205
426. Rani, M. K. S., Fathima, S. T., Gayathri, S. L., Pavani, M., & Swathi, Y. (2022). Detection of Autism Spectrum Disorder using Machine Learning. International Journal of Advanced Research in Science Communication and Technology. https://doi.org/10.48175/ijarsct-7600
427. Ransom, S. B., & Moldenhauer, J. S. (1998). Premenstrual Syndrome. The Physician and Sportsmedicine. https://doi.org/10.3810/psm.1998.04.872
428. Rathbone, A. L., & Prescott, J. (2019). Pregnancy-specific health anxiety: symptom or diagnosis?. British Journal of Midwifery. https://doi.org/10.12968/bjom.2019.27.5.288
429. Razzak, A. N., Orlando, N., Angelette, A., Kumar, V., Anderson, D. J., Hasoon, J., Viswanath, O., Kaye, A. D., Fitz-Gerald, J. S., Khater, N., & Urits, I. (2022). Rare Mental Health Disorders Affecting Urologic Care: A Comprehensive Review. Health psychology research. https://doi.org/10.52965/001c.38674
430. Reid, W. H. (2018). Psychological Factors Affecting Physical Condition. Routledge eBooks. https://doi.org/10.4324/9781315825908-30
431. Reid, W. H., Balis, G. U., & Sutton, B. (1997). The treatment of psychiatric disorders : revised for DSM-IV.
432. Reinares, M., Martínez‐Arán, A., & Vieta, E. (2019). Psychoeducation for Patients and Family Members. Cambridge University Press eBooks. https://doi.org/10.1017/9781108589802.004
433. Remschmidt, H., & Theisen, F. (2012). Early-Onset Schizophrenia1. Neuropsychobiology. https://doi.org/10.1159/000338548
434. Reuber, M., Schachter, S. C., Elger, C. E., & Altrup, U. (2009). Conditions Associated With Epilepsy. https://doi.org/10.1093/oso/9780195379532.003.0005
435. Ricciardelli, R., & Johnston, M. S. (2022). Police Mental Health and Wellness. Oxford Research Encyclopedia of Criminology and Criminal Justice. https://doi.org/10.1093/acrefore/9780190264079.013.752
436. Righter, E. L., & Sansone, R. A. (1999). Managing somatic preoccupation.. PubMed.
437. Ring, D. (2018). Editorial Comment: Comprehensive Orthopaedic Care. Clinical Orthopaedics and Related Research. https://doi.org/10.1007/s11999.0000000000000190
438. Ronad, S. V., Patail, C. S., Gondbal, S. H., TC, K., Ronad, M., Pankaja, T., Badesgol, R., & Singhal, P. K. J. (2019). Professionals in metro cities suffer from anxiety disorder. Nursing & Care Open Access Journal. https://doi.org/10.15406/ncoaj.2019.06.00198
439. Rosenblat, J. D., Kurdyak, P., Cosci, F., Berk, M., Maes, M., Brunoni, A. R., Li, M., Rodin, G., McIntyre, R. S., & Carvalho, A. F. (2019). Depression in the medically ill. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1177/0004867419888576
440. Rowe, P. C., Underhill, R., Friedman, K. J., Gurwitt, A., Medow, M. S., Schwartz, M., Speight, N., Stewart, J. M., Vallings, R., & Rowe, K. S. (2017). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer. Frontiers in Pediatrics. https://doi.org/10.3389/fped.2017.00121
441. Rozenfeld, I., & Duarte, E. M. (2014). Poster Session : PS 0614 ; Others ; Common Variable Immune Defi ciency in a Patient with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Non-Specifi c Oral Ulcers. 대한내과학회 추계학술발표논문집.
442. Ruttley, A., Ng, A., & Burnside, A. M. (2014). Medically Unexplained Symptoms and Health Anxieties: Somatic Symptom and Related Disorders. https://doi.org/10.1002/9781118560648.ch18
443. Räsänen, S., Hakko, H., Herva, A., Isohanni, M., Nieminen, P., & Moring, J. (1999). Gender Differences in Long-Stay Psychiatric Inpatients. International Journal of Mental Health. https://doi.org/10.1080/00207411.1999.11449447
444. Rüstemova, D., Genç, A., Bora, G., & Tur, B. S. (2017). A thermal dysregulation problem after breast cancer surgery; what could be?. Medicine. https://doi.org/10.1097/md.0000000000007027
445. Sabo-Graham, T., & Seay, A. R. (1998). Consultation with the Specialist: Management of Status Epilepticus in Children. Pediatrics in Review. https://doi.org/10.1542/pir.19.9.306
446. Sadiq, H., & Abakah, S. (2015). Depression and Its Relation with Blood Group According Differences (Sex).
447. Saeed, S. A., & Tj, B. (1998). Panic disorder: effective treatment options.. PubMed.
448. Sahakian, B. J., & Morein‐Zamir, S. (2011). Depression and resilience: insights from cognitive, neuroimaging, and psychopharmacological studies. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780199600434.003.0023
449. Sakakibara, R., & Katsuragawa, S. (2022). Depression and LUT (Psychogenic LUTS). https://doi.org/10.1007/978-981-16-7939-1_78-1
450. Sam, S. P., Varghese, J. J., & Kallivayalil, R. A. (2019). Religious delusions: it’s importance in psychiatry and a case report. Kerala Journal of Psychiatry. https://doi.org/10.30834/kjp.31.2.2018.149
451. Sansone, R. A., & Sansone, L. A. (2015). BORDERLINE PERSONALITY DISORDER IN THE MEDICAL SETTING: Suggestive Behaviors, Syndromes, and Diagnoses.. PubMed.
452. Santucci, K. T. T., Miranda, A. H., Oliveira, A. J. R., & Vieira, A. F. D. B. (2022). Psicologia organizacional e do trabalho e a humanização no contexto hospitalar. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.15
453. Sanz, G. L., Ruíz, E. C., & Vázquez, L. S. (2015). Síndrome confusional ag udo en pacientes de edad avanzada con fractura de fémur. Ágora de enfermería.
454. Sarkar, S., Singh, S. M., Balachander, S., & Rao, P. (2014). Chronic fatigue syndrome: A review. Medical Journal of Dr D Y Patil University. https://doi.org/10.4103/0975-2870.135252
455. Sartorius, N. (2001). Is pain a somatic symptom?. PubMed.
456. Sayar, K. (2002). [Medically unexplained symptoms].. PubMed.
457. Sayarifard, A., & Ghadirian, L. (2013). Mental health literacy in iran: an urgent need for a remedy.. PubMed.
458. Sazonov, S. (2014). EPA-0651 – The complexity of psychopathological symptom as a possible indication of mental disease's etiology. European Psychiatry. https://doi.org/10.1016/s0924-9338(14)78023-x
459. Scarella, T. M., Boland, R., & Barsky, A. J. (2019). Illness Anxiety Disorder: Psychopathology, Epidemiology, Clinical Characteristics, and Treatment. Psychosomatic Medicine. https://doi.org/10.1097/psy.0000000000000691
460. Scarlata, S., & Incalzi, R. A. (2022). Chronic obstructive pulmonary disease and asthma. Pathy's Principles and Practice of Geriatric Medicine. https://doi.org/10.1002/9781119484288.ch42
461. Scheid, T. L., & Wright, E. R. (2017). Theoretical Perspectives on Mental Health and Illness: Introduction to Part I. Cambridge University Press eBooks. https://doi.org/10.1017/9781316471289.003
462. Schildkrout, B. (2011). Characteristics That Make Somatic Diseases Difficult to Detect. https://doi.org/10.1002/9781118083598.ch3
463. Schildkrout, B. (2011). Specific Physical Signs and Symptoms. https://doi.org/10.1002/9781118083598.ch7
464. Schlotawa, L., Adang, L., Castro, M. D., & Ahrens‐Nicklas, R. C. (2019). Multiple Sulfatase Deficiency.
465. Schneiderman, N., Ironson, G., & Siegel, S. D. (2004). Stress and Health: Psychological, Behavioral, and Biological Determinants. Annual Review of Clinical Psychology. https://doi.org/10.1146/annurev.clinpsy.1.102803.144141
466. Schneier, F. R., Bruce, L. C., & Heimberg, R. G. (2014). Social Anxiety Disorder (Social Phobia). American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg18
467. Schut, C., Magerl, M., Hawro, T., Kupfer, J., Rose, M., Gieler, U., Maurer, M., & Peters, E. M. (2019). Disease activity and stress are linked in a subpopulation of chronic spontaneous urticaria patients. Allergy. https://doi.org/10.1111/all.14015
468. Seikowski, K., Harth, W., & Hermes, B. (2008). Lifestyle Drugs in Old Age – A Mini-Review. Gerontology. https://doi.org/10.1159/000173697
469. Seligman, L. D., Swedish, E. F., & Ollendick, T. H. (2014). Anxiety Disorders in Children. https://doi.org/10.1002/9781394259359.ch7
470. Semenenko, K. (2022). Мixed anxious and depressive reaction during adaptation disorder in participants during anti-terrorist operation. Journal of Education Health and Sport. https://doi.org/10.12775/jehs.2022.12.03.007
471. Senra, H., & McPherson, S. (2021). Depression in disabling medical conditions – current perspectives. International Review of Psychiatry. https://doi.org/10.1080/09540261.2021.1887823
472. Sharma, S., Kishore, J., & Gupta, V. (2014). Adolescent Mental Health: From Normalcy to Illness. Indian Journal of Youth and Adolescent Health.
473. Sharp, L. K., & Lipsky, M. S. (2002). Screening for depression across the lifespan: a review of measures for use in primary care settings.. PubMed.
474. Sharpe, M. (2020). Medically unexplained symptoms. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0623
475. Sharpe, M. (2020). Somatic symptom and related disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0638
476. Sher, L. (2015). Parental alienation: the impact on men’s mental health. International Journal of Adolescent Medicine and Health. https://doi.org/10.1515/ijamh-2015-0083
477. Sheykhi, M. T. (2020). Inevitable aging and the resultant mental disorders In developing countries: a sociological appraisal. Clinical Research and Clinical Trials. https://doi.org/10.31579/2693-4779/002
478. Shikatani, B., Nowakowski, M. E., & Antony, M. M. (2015). Illness Anxiety Disorder/Hypochondriasis. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp295
479. Siddiqui, K., Parveen, S., & Jamil, S. (2011). Multicentric Observational Studies of Polyherbal Unani Oral &amp; Local Formulations in Cases of Rheumatoid Arthritis. Planta Medica. https://doi.org/10.1055/s-0031-1273678
480. Sikter, A. (2022). Chronic psychic stress can cause metabolic syndrome through mild hypercapnia.. PubMed.
481. Silva, L. I. F. D., Souza, L. M., Gonzales, M. F., & Jurado, S. R. (2015). SLEEP DISORDERS IN CHILDHOOD. Simpósio Internacional de Neurociências da Grande Dourados.
482. Silva, L. M. R. (2015). A Demência Frontal: ou o Risco da Perda do Eu e do Outro. Psicologado.
483. Silva, T. D. O., Leite, J. R., Bezerra, W. D. S. P., Lima, M. B. L. D., & Fiorin, P. M. (2017). A DEPRESSÃO NA TERCEIRA IDADE:RELATO DE EXPERIÊNCIA DE UMA ATIVIDADE EDUCATIVA.
484. Silverman, M. N., & Deuster, P. A. (2014). Biological mechanisms underlying the role of physical fitness in health and resilience. Interface Focus. https://doi.org/10.1098/rsfs.2014.0040
485. Singh, A., & Dubey, A. P. (2015). Role of Social Support as a Mediator in Negative Stressful Life Event and Somatic Complaints of Managerial Personnel. Indian Journal of Positive Psychology.
486. Singh, P. K. (2015). Psychogenic Headache in School Going Children. Indian Journal of Health and Wellbeing.
487. Singh, S. (2015). Mental health in infancy. International Journal of Clinical & Medical Imaging. https://doi.org/10.4172/2376-0249.1000393
488. Siqueira, S. M. D. C. B., & Diefenbach, M. D. S. (2022). A prevenção do suicídio em adolescentes e jovens na faixa etária de 13 a 19 anos. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.17
489. Slaughter, J. C., & Sun, A. M. (1999). In pursuit of perfection: a primary care physician's guide to body dysmorphic disorder.. PubMed.
490. Snaith, P. (1994). Anxiety Control Training. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.1.2.57
491. Soe, K. C., & Lopez, W. L. (2022). Clinical progress note: Management of somatic symptom and related disorders in pediatric inpatients. Journal of Hospital Medicine. https://doi.org/10.1002/jhm.12947
492. Solano, L. (2019). Towards a view of health based on levels of integration and self-fulfilment: An alternative assessment model. Rivista di Psicologia Clinica.
493. Sommer, I. E., & Arango, C. (2017). Moving interventions from after to before diagnosis. World Psychiatry. https://doi.org/10.1002/wps.20454
494. Sorgen, C. (2017). ICU Stays Can Result in Long-Lasting Mental Health Problems. Psychiatric News. https://doi.org/10.1176/appi.pn.2017.9a16
495. Spasova, R. G. (2019). ETHICAL CONSIDERATIONS IN THE INTEGRATED CARE FOR PATIENTS WITH CHRONIC PAIN. Knowledge International Journal.
496. Spence, S. A. (2006). All in the mind? The neural correlates of unexplained physical symptoms. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.12.5.349
497. Spijker, A. V. ’. (2001). Personality development as predictor of psychological distress in patients of psychological suspected of lung cancer or esophageal cancer.
498. Spurgeon, A., Gompertz, D., & Harrington, J. M. (1996). Modifiers of non-specific symptoms in occupational and environmental syndromes.. Occupational and Environmental Medicine. https://doi.org/10.1136/oem.53.6.361
499. Sreshta, N., Pope, H. G., Hudson, J. I., & Kanayama, G. (2017). Muscle Dysmorphia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190254131.003.0007
500. Stahl, S. M. (2002). Can Psychopharmacologic Treatments That Relieve Symptoms Also Prevent Disease Progression?. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v63n1101
501. Stegner, A. J., Shields, M. R., Meyer, J. D., & Cook, D. B. (2013). Physical Activity, Stress Reactivity, and Stress-Mediated Pathophysiology. Routledge eBooks. https://doi.org/10.4324/9780203132678-34
502. Steinberg, J. (1981). Depression and abnormal endocrinologic tests. JAMA. https://doi.org/10.1001/jama.246.18.2032
503. Steinert, T. (1998). Schizophrenie und Gewalttätigkeit. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-2007-995277
504. Stone, J., Pal, S., Blackburn, D., Reuber, M., Thekkumpurath, P., & Carson, A. (2015). Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-150430
505. Strain, J. J., Klipstein, K., & Newcorn, J. H. (2008). Adjustment Disorders. Psychiatry. https://doi.org/10.1002/9780470515167.ch81
506. Stringer, S., Nieman, D. H., Kahn, R. S., & Derks, E. M. (2015). Genome-wide association analysis in schizophrenia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781107337459.010
507. Strosahl, K. D. (2022). ACT con el paciente multiproblemático. ABA España eBooks. https://doi.org/10.26741/978-84-09-43990-4_09
508. Sugiyama, H., & Kanba, S. (2001). [Symptomatology and diagnosis of depression].. PubMed.
509. Sunarti, S., & Helena, H. (2018). Gangguan Tidur pada Lanjut Usia. Journal of Islamic Medicine. https://doi.org/10.18860/jim.v2i1.5009
510. Szkodny, L. E., Jacobson, N. C., Llera, S. J., & Newman, M. G. (2014). Generalized Anxiety Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg19
511. Tagaya, H., Murayama, N., & Hakamata, Y. (2012). [Definitions and clinical classifications of sleep disorders].. PubMed.
512. Tait, G. (2006). A disordered approach. Office of Education Research; Faculty of Education.
513. Tanaka, M., Tajima, S., Mizuno, K., Ishii, A., Konishi, Y., Miike, T., & Watanabe, Y. (2015). Frontier studies on fatigue, autonomic nerve dysfunction, and sleep-rhythm disorder. The Journal of Physiological Sciences. https://doi.org/10.1007/s12576-015-0399-y
514. Tang‐Wai, D. F., Josephs, K. A., & Petersen, R. C. (2005). Alzheimer's disease: overview. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544873.029
515. Tariot, P. N. (1998). Comorbidity in social anxiety disorder: impact on disease burden and management.. PubMed.
516. Taylor, R., Smith, B. H., & Teijlingen, E. V. (2003). Chronic illness. https://doi.org/10.1093/oso/9780192631688.003.0015
517. Taylor, S., McKay, D., & Abramowitz, J. S. (2012). Hypochondriasis and Health‐Related Anxiety. https://doi.org/10.1002/9781118156391.ebcp002026
518. Teasell, R., & Finestone, H. M. (1999). Socioeconomic Factors and Work Disability: Clues to Managing Chronic Pain Disorder. Pain Research and Management. https://doi.org/10.1155/1999/168470
519. Telbizova, T., Aleksandrov, I., & Arnaoudova, M. (2020). DYNAMICS OF PSYCHIATRIC SYMPTOMS IN CUSHING’S SYNDROME. Journal of IMAB - Annual Proceeding (Scientific Papers). https://doi.org/10.5272/jimab.2020264.3443
520. Thach, B. T. (2003). The brainstem and vulnerability to sudden infant death syndrome. Neurology. https://doi.org/10.1212/wnl.61.9.1170
521. Thom, R. P., Silbersweig, D., & Boland, R. (2019). Major Depressive Disorder in Medical Illness: A Review of Assessment, Prevalence, and Treatment Options. Psychosomatic Medicine. https://doi.org/10.1097/psy.0000000000000678
522. Thomas, S., Zachariah, R. A., & Mathew, N. M. (2021). Perinatal Mental Health Problems –What Midwives and Nurses can do?. International Journal of Psychiatric Nursing. https://doi.org/10.37506/ijpn.v7i1.13967
523. Tollefson, G. D., Souêtre, E., Thomander, L., & Potvin, J. H. (1993). Comorbid anxious signs and symptoms in major depression. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199300840-00013
524. Tong, G., Groom, K. N., Ward, L., & Naeem, M. Y. (2021). “This Is Not the Original Timeline”: A Case Report of an Extended Dissociative Episode in a Healthy Young Male Accompanied with Severe Decline in Mental State. Case Reports in Psychiatry. https://doi.org/10.1155/2021/6619579
525. Torales, J., Malatesta, E. M., González, L. L., González, I., López, R. D. A., Barrios, J. I., García, O. E., O’Higgins, M., Castaldelli-Maia, J. M., & Ventriglio, A. (2020). Psychodermatology: An introduction to its concepts, nosology and approach models. Anales de la Facultad de Ciencias Médicas (Asunción). https://doi.org/10.18004/anales/2020.053.02.127
526. Torpy, J. M. (2006). Depression. JAMA. https://doi.org/10.1001/jama.295.3.348
527. Torpy, J. M., Burke, A. E., & Golub, R. M. (2011). Generalized Anxiety Disorder. JAMA. https://doi.org/10.1001/jama.305.5.522
528. Torres, A. R., & Smaira, S. I. (2001). Quadro clínico do transtorno obsessivo-compulsivo. Brazilian Journal of Psychiatry. https://doi.org/10.1590/s1516-44462001000600003
529. Torry, Z. D., & Weiss, K. J. (2012). Medication Noncompliance and Criminal Responsibility: Is the Insanity Defense Legitimate?. SSRN Electronic Journal.
530. Torry, Z. D., & Weiss, K. J. (2012). Medication Noncompliance and Criminal Responsibility: Is the Insanity Defense Legitimate?. The Journal of Psychiatry & Law. https://doi.org/10.1177/009318531204000208
531. Treder, N., & Jodzio, K. (2014). Prevalence and clinical specificity of fatigue symptoms in chronic fatigue syndrome, multiple sclerosis, and myasthenia gravis. Health Psychology Report. https://doi.org/10.5114/hpr.2014.43914
532. Trill, M. D. (2012). Psychological aspects of depression in cancer patients: an update. Annals of Oncology. https://doi.org/10.1093/annonc/mds350
533. Tyberghein, M., Philips, J. C., Jm, K., & Scheen, A. J. (2013). [Orthostatic hypotension: definition, symptoms, assessment and pathophysiology].. PubMed.
534. Ulyukin, I. M., & Emel’yanov, V. N. (2017). AUTOAGGRESSIVE BEHAVIOR IN YOUNG PERSONS. Bulletin of the Russian Military Medical Academy. https://doi.org/10.17816/rmmar14227
535. Unknown (2017). Brief Psychotic Disorder. The SAGE Encyclopedia of Abnormal and Clinical Psychology. https://doi.org/10.4135/9781483365817.n218
536. Unknown (2017). Illness Anxiety Disorder. The SAGE Encyclopedia of Abnormal and Clinical Psychology. https://doi.org/10.4135/9781483365817.n698
537. Uğurlu, G. K., Uğurlu, M., Kılıç, M., Apaydın, Z. K., & Çayköylü, A. (2020). Acute psychotic symptoms caused by overlapping central nervous system pathologies: a case report. European Journal of Medical Case Reports. https://doi.org/10.24911/ejmcr/173-1575624797
538. Valente, S. M. (1996). Diagnosis and Treatment of Panic Disorder and Generalized Anxiety in Primary Care. The Nurse Practitioner. https://doi.org/10.1097/00006205-199608000-00004
539. Valente, S. M. (2015). Evaluating and Managing Insomnia: Non-pharmacological Treatments. Journal of Sleep Disorders & Therapy. https://doi.org/10.4172/2167-0277.1000189
540. Vallejo, J. D. O. (2001). Detecció precoç de la depressió. Revista de la Reial Acadèmia de Medicina de Catalunya.
541. Vaughan, C., & Goldman, J. G. (2012). Psychosis and Parkinson’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-835-5_6
542. Velasco-Rey, M. C., Sánchez-Muñoz, M., Lopez, M., Trujillo-Borrego, A., & Sánchez-Bonome, L. (2012). Psychotic depression induced by Obstructive Sleep Apnoea Syndrome (OSAS): a case reported.. PubMed.
543. Viale, N., & Horne, R. M. (2022). Mental health assessment of anxiety and depression. CRC Press eBooks. https://doi.org/10.4324/9781846198304-3
544. Vicente, M. O., Gutiérrez, L. E. J. F., & Oves, M. I. R. (2011). ALCOHOLISMO CONSECUTIVO AL TRASTORNO DE PÁNICO. DOAJ (DOAJ: Directory of Open Access Journals).
545. Vigueras, P., Vigueras, J. P., Meca, R. L., Fernández, P. R., Retuerto, B. M., González, J. G., & Gaspar, J. C. (2011). La crisis económica y las urgencias hospitalarias generales y psiquiátricas. Puesta al día en urgencias, emergencias y catástrofes.
546. Vm, M., & Zi, K. (1987). [Emergency services in psychiatry].. PubMed.
547. Wadhwa, R., & Khandare, M. (2014). Stress Management through Yoga. Global Journal of Human-Social Science.
548. Wakefield, J. C., & Schmitz, M. F. (2014). Uncomplicated depression is normal sadness, not depressive disorder: further evidence from the NESARC. World Psychiatry. https://doi.org/10.1002/wps.20155
549. Walder, D. J., Statucka, M., Daly, M., & Yaffe, B. (2014). Psychotic Disorders. Psychology. https://doi.org/10.1093/obo/9780199828340-0151
550. Warnock‐Parkes, E., Wild, J., Thew, G. R., Kerr, A., Grey, N., & Clark, D. M. (2022). ‘I’m unlikeable, boring, weird, foolish, inferior, inadequate’: how to address the persistent negative self-evaluations that are central to social anxiety disorder with cognitive therapy. The Cognitive Behaviour Therapist. https://doi.org/10.1017/s1754470x22000496
551. Weeß, H.-G. (2006). Multifaktorielles Symptom vieler Schlafstörungen - Tagesschläfrigkeit birgt ein hohes Risiko. Der Klinikarzt. https://doi.org/10.1055/s-2006-942076
552. Wei, L., Benhui, S., Lanping, J., & Xiaolin, T. (2014). The Impact of Health Education or Health of the Victims of the Earthquake in Disaster Area. Advances in Social Science, Education and Humanities Research/Advances in social science, education and humanities research. https://doi.org/10.2991/asshm-14.2014.7
553. Weigel, G. (2014). Critical Additions Required. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2014.0488b
554. Weiner, H. (1987). Some Unexplored Regions of Psychosomatic Medicine. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000288012
555. Wessely, S. (2001). Chronic Fatigue: Symptom and Syndrome. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-134-9_part_2-200105011-00007
556. Wetherell, J. L., Lang, A. J., & Stein, M. B. (2007). Anxiety Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-960-8_5
557. Winter, A., & Buhlmann, U. (2013). Spieglein, Spieglein an der Wand … Klinische Charakteristika der körperdysmorphen Störung. Zeitschrift für Psychiatrie Psychologie und Psychotherapie. https://doi.org/10.1024/1661-4747/a000155
558. Wise, M. P., & Frost, P. C. (2018). Critical illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199568741.003.0147
559. Wissow, L. S. (2021). Anxiety and Trauma-Related Distress. Pediatric Care Online. https://doi.org/10.1542/aap.ppcqr.396464
560. Wittmann, C. W. (2020). Panic Attacks and Anxiety Disorders. https://doi.org/10.2310/em.4192
561. Wolkowitz, O. M. (2018). Accelerated biological aging in serious mental disorders. World Psychiatry. https://doi.org/10.1002/wps.20546
562. Wong, V., & Chung, B. H. (2006). Evaluating a Child with Partial Developmental Delay (ParDD), Global Developmental Delay (GDD)/Mental Retardation (MR): Clinical Expertise Based or Evidence-Based?. Current Pediatric Reviews. https://doi.org/10.2174/157339606776894621
563. Woo, B. K. (2011). Unrecognized medical disorders among older patients in psychiatric emergency service. International Journal of Geriatric Psychiatry. https://doi.org/10.1002/gps.2673
564. Wout‐Frank, M. V. ‘. (2006). The nature of emotional abnormalities in schizophrenia: Evidence from patients and high-risk individuals.
565. Wïttchen, H. (2001). Epidemiology of Affective Disorders. Contemporary psychiatry. https://doi.org/10.1007/978-3-642-59519-6_101
566. Wïttchen, H., & Hoyer, J. (2001). Generalized anxiety disorder: nature and course.. PubMed.
567. Yennurajalingam, S., & Bruera, É. (2015). Fatigue and asthenia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199656097.003.0081
568. Yoshimasu, K., Takemura, S., Fukumoto, J., & Miyashit, K. (2012). Self-Reported Symptoms Related to Depression and Suicidal Risk. InTech eBooks. https://doi.org/10.5772/31630
569. Yunus, M., & Chaudhary, P. K. (2022). Impact of Mental Illness (Schizophrenia) on Family. Journal of Clinical Research and Applied Medicine. https://doi.org/10.5530/jcram.2.1.1
570. Yutzy, S. H. (2015). Somatic Symptom and Related Disorders: Somatic Symptom Disorder, Illness Anxiety Disorder, and Conversion Disorder. Psychiatry. https://doi.org/10.1002/9781118753378.ch62
571. Zj, L. (1986). Somatization: a borderland between medicine and psychiatry.. PubMed.
572. Zoellner, L. A., Graham, B., & Bedard‐Gilligan, M. (2019). Trauma- and Stressor-Related Disorders. Routledge eBooks. https://doi.org/10.4324/9780429028267-10
573. Zuraida, N. (2009). Interactions Between Psychiatric Disorder And Physical Illness. The Malaysian journal of psychiatry.
574. Çelik, A. S., & Pasinlioğlu, T. (2013). KLİMAKTERİK DÖNEMDE YAŞANAN SEMPTOMLAR VE HEMŞİRENİN ROLÜ.
575. Édouard, T., & Tauber, M. (2011). Syndromic growth disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199235292.003.7086
576. Šonka, K., & Volná, J. (2006). Medical factors of falling asleep behind the wheel.. PubMed.